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1. Introduction
1.1 Gap junctions
Proper organic function and organization require cellular interaction and communication. 
Cells communicate via diverse mechanisms, i.e. ligands and their receptors, mediators, 
second  messengers,  electrical  impulses  and  /  or  gap  junctions.  Gap  junctions,  tight 
junctions and desmosomes connect cells to each other, whereas gap junctions enable the 
intercellular communication. This communication coordinate physiological processes in 
many tissues, for example the synchronized contraction of cardiomyocytes in the heart. 
Gap junctions are intercellular conduits formed between adjacent cells, allowing direct 
metabolic  and  electrical  coupling  of  contacting  cells  by  diffusional  exchange  of 
metabolites, ions, and second messengers up to 1.8 kDa in molecular mass (c.f. Willecke 
et al., 2002; Neijssen et al., 2005). Generally, gap junctions are characterized by adjacent 
cell membranes  narrowed  down to 2-4 nm instead of the usual 20-30 nm  (Revel and 
Karnovsky, 1967).
Gap junction mediated communication is described in almost all cell types in mammals 
except differentiated skeletal muscle, erythrocytes, thrombocytes and sperm cells (Gilula 
et al.,  1978). However,  the precursors of these cells express gap junctions. The other 
gene family in vertebrates which was suggested to be analogous to connexin gap junction 
channels are pannexins (Bruzzone et al., 2003), however these channels seem not to be 
capable to form intercellular channels but assembled into functional cell surface channels 
(Penuela  et  al.,  2007).  In invertebrates  innexins  generate  gap junctions  (Bauer  et  al., 
2005). The following introduction is focused on connexins which also are the subject of 
this PhD thesis.
1.1.1 Structure of gap junction channels
Each cell  contributes a hemichannel (or connexon) composed of six protein subunits, 
termed connexins. Connexins are transmembrane proteins characterized by a cytoplasmic 
amino terminus,  four transmembrane domains,  two extracellular  and one cytoplasmic 
loop and a regulatory carboxy terminal region. Connexins oligomerize to connexons, also 
1
                                                                                                                           Introduction  
called ‘‘hemichannels’’ which can dock to each other in contacting plasma membranes 
and form intercellular conduits. Different connexin isoforms that are coexpressed in the 
same cell can aggregate to homomeric channels, i.e. they consist of the same Cx isoforms 
within  the  single  hemichannel.  Heteromeric  channels,  i.e.  different  Cx  isoforms  are 
expressed within the single hemichannel. Homotypic channels, i.e.  both hemichannels 
have the same Cx isoform composition and heterotypic channels, i.e. both hemichannels 
are composed of different Cx isoforms (Kumar and Gilula, 1996; Brink et al., 1997) (Fig. 
1.1).
Figure 1.1: Organization and topology of gap junction plaques. (A) Two hemichannels in plasma 
membranes  of  two adjacent  cells  can  dock  to  each  other forming  a  gap  junctional  channel. 
Connexons (hemichannels) consist of six connexin subunits of the same connexin isoform (1, 
homomeric)  or  different  connexin  isoforms  (2,  heteromeric).  Gap  junctions  containing  two 
identical  connexons are  called homotypic  (1,  2),  those  composed of  different  connexons are 
termed  heterotypic  (3).  (B)  Connexins  are  transmembrane  proteins  containing  four 
transmembrane  domains,  an  amino-terminal  domain,  cytoplasmic  loop  and  carboxy-terminal 
domain and two extracellular loops. The extracellular loops are connected by disulfide bonds (S-
S) between the highly conserved cystein residues. (Söhl et al., 2005)
2
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1.1.2 Functions of gap junction channels and hemichannels
Gap  junction  channels  (GJC)  allow  mutual  intercellular  diffusion  of  ions,  second 
messengers or metabolites and are assumed to be necessary for normal embryogenesis 
and maintenance of organ functions in the mammalian organism (Bennett & Verselis, 
1992).  These channels facilitate electric and metabolic communication between cells of 
the  cardiovascular,  the  central  nervous  system  and  other  tissues.  GJCs  allow  the 
diffusional exchange of metabolites such as sugars, amino acids, nucleotides and ions 
(Bennett  and Verselis 1992) or second messengers such as cAMP, Ca2+,  NAD+ or IP3 
between  contacting  cells  (Bruzzone  et  al.,  2001).  Thereby  gap  junction  channels 
composed of different connexin isoforms can exhibit different permeability to molecules 
such as cAMP or inositol-1,4,5-trisphosphate (Niessen et al., 2000; Bedner et al., 2006). 
Also  permeation  of  small  peptides  up to  a  molecular  mass  of  1.8  kDa was recently 
reported which provides a mechanism of antigen acquisition for crosspresentation during 
immune responses (Neijssen et al., 2005). 
During  the  last  few  years,  the  physiological  role  of  unopposed  gap  junctional 
hemichannels (connexons) has become a focus of gap junctional research (Bennett et al., 
2003; Ebihara, 2003; Stout et  al.,  2004; Spray et al.,  2006).  Recent data suggest that 
unpaired hemichannels can transiently open under cellular stress, i.e. hypoxia (Evans et 
al.,  2006).  These  hemichannels  have  been  proposed  to  be  also  permeable  to  second 
messengers  such  as  ATP or  NAD+,  indicating  their  potential  involvement  in  cellular 
signaling  (Bruzzone  et  al.,  2001;  Evans  et  al.,  2006;  Stout  et  al.,  2002)  (Fig.  1.2). 
However, the molecular identity of hemichannels and their physiological role are still 
controversially  discussed  (Spray  et  al.,  2006).  For  example,  besides  connexin 
hemichannels, also pannexins and the purinergic P2X7 receptor have been suggested to 
be involved in the cellular release of ATP (Spray et al., 2006).
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Figure  1.2: Proposed  functions  of  gap  junction  channels  and  hemichannels.  Gap  junctions 
mediate intercellular communication by allowing exchange of small molecules like metabolites 
or second messengers up to 1.8 kDa molecular mass. Connexons or hemichannels on their way to 
a  gap  junction  plaque  can open transiently,  mediating efflux  of  ATP,  NAD+,  ions  or  second 
messengers and influx of Ca2+ and other ions.
1.1.3 Regulation of gap junction channels
In general three factors are known which regulate the extent of gap junctional coupling: 
the open probability of a channel, the single channel conductance and the number of gap 
junction channels. The open probability can be regulated by several factors. The increase 
of  cytoplasmic  Ca2+ concentration,  for  example  as  a  consequence  of  an  injury  of 
neighboring cell closes the channels (Rose and Löwenstein, 1975). An acidification of 
intercellular milieu has the same effect, whereas the pH-sensitivity is specific for each 
connexin isoform (Wang et al., 1996; Stergiopoulos et al., 1999). The third possibility of 
posttranslationally  regulate  the  open  probability  of  a  gap  junction  channel  is  the 
phosphorylation, whose effect depends on the site involved (Lampe and Lau, 2004; Solan 
et al., 2007). Recently, phosphorylation of serine residue S365 has been described as a 
gatekeeper event for Cx43 containing channels, which may represent a mechanism to 
prevent cells from ischemia (Solan et al., 2007). Additionally, intermolecular interactions 
can influence the channel function (Toyofuku et al., 1998; Giepmans et al., 2001; van 
Zeijl et al., 2007). A number of catalytic and non-catalytic proteins serve as interaction 
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partners of connexins, for example,  the zonula occludens 1 (ZO-1) protein.  Recently, 
ZO-1 was described to be essential for the regulation of Cx43 containing channels by 
phosphatidylinositol bisphosphate hydrolyzing receptors (PLCß3) (Fig. 1.3). 
Figure  1.3:  Proposed  model  for  ZO-1  dependent  regulation  of  gap  junctional  coupling  in 
fibroblasts.  ZO-1  binds  to  Cx43  via  its  PDZ2 domain  and  to  PLCß3  via  its  PDZ3 domain 
assembling the two proteins into a complex and mediating gap junction channel phosphorylation 
by PLCß3. Phosphatidylinositol bisphosphate (PIP2) is a crucial substrate for this reaction. (van 
Zeijl et al., 2007). 
The  regulation  of  gap  junctional  coupling  by  the  number  of  gap  junction  channels 
thereby depends  on  the  connexin  expression,  the  trafficking  of  hemichannels  to  the 
membrane and the protein turnover (Musil et al., 2000; Evans and Martin, 2002).
1.2 Connexins in human and mouse
Until now, 21 human and 20 mouse genes have been described (Söhl and Willecke, 2004) 
coding for connexin proteins. The orthologous genes in mouse and man exhibit different 
degrees of protein sequence identity varying from 68% (between mouse Cx39 to  the 
human Cx40.1) to 99% (Cx43 and Cx45 in both species). Connexins with high sequence 
identity also show a similar expression pattern among the different species (Söhl et al., 
2003).
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1.3 Connexin associated human disease
Mutations in connexin genes lead to alterations in important biological functions of gap 
junction  channels  and  hemichannels,  disturbing  intercellular  communication  (Laird, 
2006) and /  or  modifying hemichannel  activity (Lai  et  al.,  2006, Dobrowolski et  al., 
2007)  thus  causing  and  aggravating  symptoms of  hereditary human disorders.  These 
diseases  (Table  1.1)  can  be  divided  into  seven major  classes:  neuropathic  or  myelin 
disorders,  non  syndromic  and  syndromic  deafness,  skin  diseases,  cataracts, 
oculodentodigital  dysplasia  and  idiopathic  atrial  fibrillation.  Connexin32  (Cx32) 
mutations were first described to be associated with the X-linked Charcot-Marie-Tooth 
disease (Bergoffen et al., 1993). Currently more than 270 mutations in the Cx32 gene are 
known to cause this disease. The second neuropathic connexin disorder is the Pelizaeus-
Merzbacher-like disease, caused by nine known recessive mutations in the Cx47 gene 
(Uhlenberg et al., 2004, Bugiani et al., 2006, Wolf et al., 2007, Salviati et al., 2007). Non-
syndromic deafness  is  the most  frequent  phenotype  of  connexin linked diseases with 
mutations in Cx26, Cx30 or Cx31 (http://davinci.crg.es/deafness/index.php). In addition, 
some mutations in Cx26 and Cx31 lead to syndromic deafness, i.e. deafness accompanied 
by skin disorders like palmoplantar keratoderma (Richard et al., 1998, Uyguner et al., 
2002) and palmoplantar hyperkeratosis (Heathcote et al., 2000), mutilating keratoderma 
(Vohwinkel syndrome) (Maestrini et al., 1999), keratitis and ichthyosis (KID) (Richard et 
al.,  2002)  or  erythrokeratodermia  variabilis  (EKV)  (Lopez-Bigas  et  al.,  2001).  The 
associated  skin  disorders  also  occur  alone  leading  to  hidrotic  ectodermal  dysplasia 
(Clouston syndrome) (Lamartine et al., 2000) and EKV as a result of connexin30, 30.3 or 
31 mutations (Richard, 2000, Macari et al., 2000). Pathological mutations of connexins in 
the lens (Cx46 and Cx50) are one of the genetic reasons for the development of zonular 
pulverulent cataracts (Shiels  et  al.,  1998, Mackay et  al.,  1999), whereas mutations in 
Cx43, which is expressed in many cell types, cause the rare oculodentodigital dysplasia 
(ODDD). More than 30 mutations harboring point mutations, codon duplications, and a 
frame shift in the Cx43 coding DNA were reported to lead to the pleiotropic phenotype of 
ODDD (Paznekas et al., 2003). A new link between human diseases and connexins has 
recently  been  reported.  Gollob  et  al.  (2007)  described  four  mutations  in  Cx40  gene 
causing idiopathic atrial fibrillation, thereby underlining the importance of gap junctional 
6
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function in cardiac physiology. 
Table 1.1: Human and mouse connexin genes,  corresponding human disease and phenotypic 
alterations in null mutated mice.
7
Human 
connexin 
gene 
protein 
Human disease 
Mouse 
connexin 
gene 
protein 
Phenotype of connexin null mutated  
mouse 
GJA1 
Cx43 
Oculodentodigital dysplasia (ODDD) 
Gja1 
Cx43 
Cardiac dysmorphogenesis 
(postnatal lethality) 
GJA3 
Cx46 
Zonular pulverulent cataract-3 (CZP3) 
Gja3 
Cx46 
Zonular nuclear cataracts 
GJA4 
Cx37 
Predisposition to arterosclerosis 
Gja4 
Cx37 
Female Sterility 
GJA5 
Cx40 
Idiopathic atrial fibrillation 
Gja5 
Cx40 
Atrial arrhythmias 
GJA6P 
--- 
--- 
Gja6 
Cx33 
--- 
GJA8 
Cx50 
Zonular pulverulent cataract-1 (CZP1) 
Gja8 
Cx50 
Microphthalmia, congenital cataracts 
GJA9 
Cx59 
--- --- --- 
GJA10 
Cx62 
--- 
Gja10 
Cx57 
Coupling deficiency in horizontal cells 
GJB1 
Cx32 
X-linked Charcot-Marie-Tooth disease (CMTX) 
Gjb1 
Cx32 
Late-onset progressive neuropathy, 
decreased glycogen degradation, increased 
liver carcinogenesis 
GJB2 
Cx26 
Non-syndromic and syndromic deafness, 
palmoplantar hyperkeratosis, keratitis-ichthyosis-
deafness (KID), Vohwinkel syndrome 
Gjb2 
Cx26 
Lethality at ED 11 
GJB3 
Cx31 
Non-syndromic and syndromic deafness, 
Erythrokeratodermia variabilis (EKV) 
Gjb3 
Cx31 
Transient placental dysmorphogenesis 
GJB4 
Cx30.3 
Erythrokeratodermia variabilis (EKV) 
Gjb4 
Cx30.3 
reduced behavioral response to a vanilla 
scent, no hearing anomalies 
GJB5 
Cx31.1 
--- 
Gjb5 
Cx31.1 
Impaired placental development 
GJB6 
Cx30 
Non-syndromic deafness, hydrotic ectodermal 
dysplasia (Clouston syndrome) 
Gjb6 
Cx30 
Hearing insufficiency, no skin phenotype 
GJB7 
Cx25 
--- 
--- 
--- 
--- 
GJC1 
Cx45 
--- 
Gjc1 
Cx45 
Lethality at ED 10.5 
GJC2 
Cx47 
Pelizaeus-Merzbacher-like disease-1 
Gjc2 
Cx47 
Vacuoliation of nerve fibers 
GJC3 
Cx30.2 
--- 
Gjc3 
Cx29 
Development of hearing (?) 
GJD2 
Cx36 
Predisposition to juvenile myoclonic epilepsy 
Gjd2 
Cx36 
Night blindness 
GJD3 
Cx31.9 
--- 
Gjd3 
Cx30.2 
Increased atrio-ventricular condunction 
velocity 
GJD4 
Cx40.1 
--- 
Gjd4 
Cx39 
--- 
GJE1 
Cx23 
--- 
Gje1 
Cx23 
--- 
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1.3.1 Connexin43 mutations lead to Oculodentodigital dysplasia (ODDD)
Oculodentodigital  dysplasia  (ODDD)  is  an  autosomal  dominantly  inherited  disorder 
characterized by anomalies of face, eyes, limbs and teeth with a high manifestation and 
variable expression (Judisch et al.,1979). The most common symptoms are syndactyly, 
enamel  hypoplasia,  microdontia,  microcornea  and  craniofacial,  skeletal  and  skin 
alterations (Gillepsie, 1964; Weintraub et al., 1975; Fara et al., 1977; Nivelon-Chevallier 
et  al.,  1981;  van  Steensel  et  al.,  2005).  Furthermore,  some neurological  and  cardiac 
symptoms  were  described,  such  as  spastic  paraparesis,  ataxia,  progressive 
leukodystrophy (Loddenkemper et al., 2002) and arrhythmias, which were discussed as 
the reason for the sudden cardiac death in an affected family (Paznekas et al., 2003). 
ODDD is caused by mutations in the GJA1 gene, coding for connexin43 (Cx43) protein 
(Paznekas et al., 2003) (Fig.1.4), which is expressed in many cell types and has essential 
functions during embryonic development.
Figure 1.4: Clinical symptoms of ODDD and Cx43 mutations found in affected patients. (A) 
Child  suffering  from  ODDD  showing  craniofacial  malformations.  (B  and  D)  Soft  tissue 
syndactyly of an affected person. (C) Microcornea, long nasal bridge and dental malformations in 
an ODDD patient. (E) Mutations of Cx43 causing ODDD. (Paznekaz et al., 2003; Farsson et al., 
2004; Debeer et al., 2005 ; Laird, 2006)
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Currently, over 30 mutations in the GJA1 gene are known to cause ODDD, but only one 
frameshift mutation in the carboxy terminal part of Cx43 has been described leading to a 
premature stop and a truncation of the protein. Patients carrying this mutation develop 
palmoplantar keratoderma (van Steensel et al., 2005). Morphological alterations of the 
skin and a defect of the epidermal water barrier have been observed in Cx43K258stop 
mouse mutants lacking the last 125 aminoacid residues of the carboxy terminal region of 
Cx43  (Maass  et  al.,  2004).  Although,  striking  differences  like  the  recessivity  of  the 
Cx43K258stop mutation or the dissimilarity of the skin phenotypes are obvious between 
the two species, both mutations in human and mice confirm the transspecies importance 
of the carboxy terminal Cx43 region. Many phosphorylation and protein binding sites are 
located in this region. Their loss in mice results frequently in lethality shortly after birth 
(Maass et al., 2004). 
Most ODDD associated mutations are point mutations leading to amino acid exchanges 
within the first half of the protein. Some of the mutations like Y17S, G21R, I31M, A40V, 
F52dup, L90V, I130T, K134E, G138R, G143S, R202H (Seki et al., 2004; Roscoe et al., 
2005; Shibayama et  al.,  2005;  Lai et  al.,  2006; Dobrowolski et  al.,  2007) have been 
functionally  analyzed  regarding  GJIC and hemichannel  activity  in  cultured  cells.  All 
tested mutations disturbed  dominantly Cx43 mediated coupling but differently affected 
the hemichannel activity. Thus, loss-of-function (Y17S, G21R, A40V, F52dup, L90V and 
I130T) (Lai et al., 2007) and gain-of-function (I31M, G138R and G143S) (Dobrowolski 
et  al.,  2007)  mutations  have  been  identified.  Some of  the  mutations  associated  with 
neurological abnormalities lead to hemichannel dysfunction (Y17S, L90V and I130T) or 
increase in their activity (G138R). However, the physiological functions of hemichannels 
or even their identity are still under debate (Spray et al., 2006). It is not clear, whether the 
disturbed hemichannel activity is  responsible  for these symptoms.  Cx43 null  mutated 
mice are lethal shortly after birth and thus cannot be used as mouse models for ODDD. 
Thus,  mice  carrying  point  mutations  in  the  GJA1 gene  have  been  developed.  Three 
mouse  models  were  generated,  showing  ODDD  like  phenotypes,  the  Cx43G61S 
(Flenniken  et  al.,  2005),  Cx43G138R  (Dobrowolski  et  al.,  2008)  and  Cx43I130T 
(Kalcheva et al., 2007) expressing mice. 
The generation and characterization of the Cx43G138R expressing mice are the major 
part of this PhD work.
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1.4 The mammalian heart
The mammalian heart consists of four chambers: two atria and two ventricles that are 
arranged in a parallel manner (Fig. 1.5A).  The right half of the heart pumps the blood 
from the body to the lungs (pulmonary circulation) where it is oxygenated and flows 
back  to  the  left  half  of  the  heart  from where  it  is  driven  into  the  body  (systemic 
circulation) (Fig. 1.5B). 
Figure  1.5:  Anatomy  of  mammalian  heart  and  the  cardiovascular  arrangement.  (A)  The 
mammalian heart  is composed of the right and left atria (RA, LA) and right and left ventricles 
(RV, LV). The conduction system is composed of the sinoatrial node (SAN), the atrioventricular 
node (AVN) and the atrioventricular bundle (AVB), the bundle branches (BB), and the peripheral 
ventricular  conduction  system (PVSC).  PV,  pulmonary veins;  S/I  CV,  superior/inferior  caval 
vein;  CFB,  central  fibrous  body;  MV, mitral  valve;  TV,  tricuspid valve;  END, endocardium; 
MYO, myocardium.(B) The  cardiovascular arrangement. The right half of the heart drives the 
pulmonary circulation which ends in the left half of the heart. From there the blood is pumped 
into the body driving the systemic circulation. (Moorman and Christoffels, 2003, modified)
The coordinated contraction of the heart is garanteed by electrical stimulation of each 
portion  of  the  muscle  via  its  conduction  system.  The  cardiac  conduction  system is 
composed of the pacemaking tissues of the sinoatrial node (SAN) and the atrioventricular 
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node (AVN) as well as the so called fast-conducting components (atrioventricular bundle 
(AVB), the bundle branches and the peripheral ventricular conduction system (PVSC)). 
The cardiac impulse is initiated in the pacemaker cells of the SAN, propagated to the 
crista terminalis through the right and left atria. The stimulus reaches the AVN where its 
velocity of propagation decreases (in the human heart) from 0.5-1 m/s to 0.05 m/s. This 
delay is discussed to be necessary for the sequential contraction of atria and ventricles 
(Mazgalev and Tchou, 2000) and the filtering of high atrial frequencies such as observed 
during atrial fibrillation protecting the ventricle against tachyarrhythmias (Dobrzynski et 
al., 2003). Entering the His bundle the velocity of the excitation rapidly increases up to 2 
m/s and is transmitted with this velocity to the Purkinje fibers resulting in a contraction 
of the ventricles. 
1.4.1 Gap junctions in the heart: expression and function
Gap junctions in the mammalian heart mediate metabolic and electrical communication 
between myocytes and isolating cells in working and conductive myocardium allowing 
proper  cardiac  contraction  and impulse  propagation.  Today,  four  connexin  genes  are 
known to be expressed in the mouse heart: Cx30.2, Cx40, Cx43 and Cx45 (Fig. 1.6). 
Cx43 is the major connexin protein of the heart, expressed in the working myocardium of 
the atria and the ventricle and a part of the conduction system, the Purkinje fibers (Beyer 
et al., 1989; Gourdie et al., 1993; Coppen et al., 1999a). Cx40, the connexin with the 
highest single channel conductance (180 pS), is coexpressed with Cx43 in the atria, but 
also in the entire conduction system except  the SA-node,  i.e.  the His bundle,  bundle 
branches and Purkinje fibers (Kirchhoff et al.,1998; Coppen et  al.,  1999b). Cx45 and 
Cx30.2,  connexins  with  the  lowest  single  channel  conductance  (32  pS  or  9  pS, 
respectively), are coexpressed in all cardiac tissues, i.e. the SA node, AV node, AV bundle 
and the bundle branches (Coppen et al., 1999a, b; Kreuzberg et al., 2005). 
The expression of Cx40, Cx43 and Cx45 has been confirmed in the human heart (Severs 
et al., 2004), whereas the human Cx30.2 homolog Cx31.9 could not be found neither in 
the adult nor the embryonic heart (Sara Segschneider, unpublished data) underlining the 
differences in the cardiac morphology between the two species.
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Figure 1.6: Connexin expression pattern and the spread of excitation illustrated in a schematic 
human heart. (Netter, 1993, modified)
1.4.2  Disturbed cardiac conduction in connexin deficient mice
The deletion of every cardiac connexin leads to a disturbance of cardiac physiology. The 
ubiquitous deletion of Cx43 resulted in postnatal death due to a failure in pulmonary gas 
exchange as  a result  of  morphologically altered right  ventricular  outflow tract  in  the 
mutated heart (Reaume et al., 1995). A specific deletion of Cx43 in cardiomyocytes or 
the tamoxifen induced systemic deletion in adult mice lead to an obvious disturbance of 
impulse propagation in the ventricle and severe tachyarrhythmias (Gutstein et al., 2001; 
van Rijen et al., 2004; Eckardt et al., 2006). 
Kirchhoff  et  al.  (1998;  2000)  had  demonstrated  the  importance  of  Cx40  and  Cx43 
mediated intercellular communication in normal heart physiology. Cx40 deficiency in the 
mouse  led  to  a  disturbance  of  intercellular  communication  in  atrium and conduction 
system as shown in a prolongation of the atrial and ventricular ECG parameters and atrial 
arrhythmia (Kirchhoff et al.,  1998). Furthermore, Cx40+/-/Cx43+/- mice also exhibited 
alterations in ventricular conduction (Kirchhoff et al., 2000). Thus, the results obtained 
from these mouse mutants widely seem to reflect the situation in human patients. Both, 
the human Cx40 mutations or the Cx40 deficiency in mouse, disturb the proper impulse 
propagation in the heart generating an arrhythmic substrate due to loss of gap junctional 
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coupling. 
An  ubiquitous  deletion  of  Cx45  or  the  cardiac-actin  Cre  mediated  deletion  of  this 
connexin  gene  resulted  in  early  embryonic  lethality  due  to  defective  vascular 
angiogenesis (Krüger et al., 2000) or  cardiac cushion defects (Nishii et al., 2003). The 
observed  vascularization  defects  are  most  probably  a  secondary  effect  of  a  cardiac 
insufficiency as observed in Cx45floxKICx36:alphaMyHC-Cre mice in which Cx45 is 
exchanged  by  Cx36  specifically  in  cardiomyocytes  (Marina  Frank,  Diploma  thesis, 
2008). 
Cx30.2 decelerates the impulse propagation in the cardiac conduction system (Kreuzberg 
et al., 2006). The loss of Cx30.2 in the AV node lead to a significantly shorter PQ interval 
than in wild-type littermates. Cx30.2 exhibits the lowest unitary conductance of all gap 
junction channels (Kreuzberg et al., 2005) and shows additionally a high hemichannel 
activity (Bukauskas et al., 2006) which together may slow down the signal propagation in 
the AV node of mice. 
1.4.3 Gap junction alterations in human heart failure
Altered  gap  junctional  communication  can  cause  certain  human  heart  diseases. 
Alterations have been described for Cx40, Cx43 and Cx45 in human heart failure (Severs 
et  al.,  2004;  Kalcheva  et  al.,  2007;  Bruce  et  al.,  2008).  In  the  diseased  ventricular 
myocardium  two  principal  gap  junction-related  alterations  have  been  reported: 
disturbances  in  the  distribution  of  gap  junctions  and  reduced  levels  of  their  major 
component,  Cx43. The myocardial  zone,  bordering infarct  scar tissue in ventricles of 
patients  with  ischaemic  heart  disease  shows  such  an  alteration  of  Cx43  distribution 
(Smith et al., 1991). A reduction in the expression of Cx43 has also been described in the 
diseased  ventricles  (Peters  et  al.,  1993;  Kaprielian  et  al.,  1998).  These  observed 
reductions in expression in most cases less than 50%, which in the mouse heart does not 
seem to affect its proper function (van Rijen et al., 2004). Besides Cx43 remodeling and 
phosphorylation  as  shown in ischaemic  rat  hearts  (Beardslee et  al.,  2000)  a  changed 
intermolecular interaction of Cx43 to its partner ZO-1 seems to play an important role in 
arrhythmogenesis by decreasing the size of Cx43 gap junctions  (Bruce et al., 2008).  In 
addition,  upregulation  of  Cx45  was  observed  in  the  failing  human  heart,  which  is 
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discussed as a compensatory attempt of the diseased tissue to maintain the gap juctional 
function (Yamada et al., 2003).
Recently, mutations in the GJA5 gene, coding for Cx40, have been described in patients 
suffering from idiopathic atrial fibrillation (Gollob et al., 2006). Lymphocytic blood and 
cardiac tissue samples were analyzed by PCR amplification and sequencing of the GJA5 
gene. Besides one obvious polymorphism (M163S), three mutations (P88S, G38D and 
A96S) in Cx40 were detected in 4 out of 15 patients with idiopathic atrial fibrillation. 
Notably, two of the ascertained mutations were somatic, i.e.  they were originated and 
expressed only in the heart, but could not be found in lymphocytic DNA. The Cx40 A96S 
mutation was genetically inherited. The same publication (Gollob et al., 2006) described 
functional disturbances of these mutations regarding trafficking, gap junctional coupling 
in  Xenopus  oocytes  and  their  influence  on  wild-type  Cx40  and  Cx43  function.  The 
mutations (P88S and G38D) which cause defective intracellular  protein trafficking as 
well as the plaque forming mutation (A96S) clearly showed a reduction in intercellular 
communication, dominance on wild-type Cx40 and trans-dominance on wild-type Cx43 
mediated electrical  coupling.  These findings suggest  that  the strong reduction of  gap 
junction  mediated  cellular  communication  in  the  heart  can  cause  the  observed  atrial 
fibrillation. Others described the predisposition to atrial arrhythmia in patients carrying 
specific  polymorphisms  in  the  promoter  region  of  Cx40 (Groenewegen et  al.,  2003) 
which  led  to  attenuated  activity  of  this  regulatory  element  and  decreased  Cx40 
expression (Juang et al., 2007). 
In  the  last  years  antiarrhythmic  peptides  targeting  Cx43  gap junction  channels  were 
discovered (Eloff et al., 2006). Rotigaptide is one of these peptides which increase gap 
junctional coupling (Axelsen et al., 2007). However, the detailed molecular mechanisms 
behind the  action of  antiarrhythmic  peptides  remain  unclear.  Recently,  effects  on the 
phosphorylation of Cx43 in rat hearts have been described suggesting a more frequent 
opening of the gap junction channels (Wang et al., 2007). 
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1.5 General developmental processes in limb and bone
Morphogenesis is a fundamental aspect of developmental biology which consists of cell 
proliferation, cellular differentiation and tissue patterning.  
Several classes of molecules are particularly important during morphogenesis. The first 
one comprises the morphogens which are diffusible molecules acting through binding to 
their  specific  receptors  and  carrying  signals  that  control  cell  differentiation  in  a 
concentration  dependent  manner.  Morphogen  gradients  induce  different  cell  types  in 
distinct spatial order. Distinct concentration thresholds induce or maintain the expression 
of  diverse  target  genes.  The  second  important  class  of  molecules  involved  in 
morphogenesis  are  transcription  factors  which  are  capable  to  determine  cell  fate  by 
modulation of gene expression and regulation of downstream cascades. Another class of 
molecules  involved  in  morphogenesis  are  cell  adhesion  molecules  acting  during 
fundamental developmental processes like gastrulation. 
The combinations of target gene expression lead to the development of distinct cell types 
in developing tissues. The key molecules in the development of limb and bone are sonic 
hedgehog  (Shh),  fibroblast  growth  factors  (FGFs)  and  bone  morphogenic  proteins 
(Bmps). Their effects and interactions are described in detail in the following chapters. 
1.5.1 Development of the limb bud
The limb develops out of a so called limb field, a morphogenetic area dependent on the 
homeobox c6 (Hoxc6) gene expression and retinoid acid signalling. The limb formation 
from the limb field occurs out of an interaction between the mesenchymal cells and the 
overlying ectodermal cells. Directed from the lateral mesoderm and the myotome, cells 
migrate to the limb field and proliferate to form the limb bud (Fig.  1.7A).  Here,  the 
lateral cells produce the skeletal portions of the limb, while the myotome cells produce 
the muscle components. 
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Figure 1.7: Patterning of vertebrate limb bud. (A) Scanning electron micrograph of a chicken 
limb bud at 4th day of incubation. The line points at a thickened edge of the limb, the apical 
ectodermal  ridge  (AER).  (B)  Schematic  expression  pattern  of  the  key  morphogens  of  limb 
development.  Ectodermal  cells  express  Notch,  fibroblast  growth  factor  4  (FGF4),  FGF8 and 
Wnt7a,  whereas LIM homeobox transcripition factor  1  (Lmx1),  bone morphogenic  protein 2 
(Bmp2) or sonic hedgehog (Shh) are expressed by mesenchymal cells. Posterior mesenchyme 
secreting Shh has pattern-organizing activity is also called zone of polarizing activity (ZPA). 
(Alberts et al.,  2002, modified)
The lateral mesodermal cells express fibroblast growth factor 10 (FGF10) and induce the 
cells from the apical ectodermal ridge (AER) to express FGF8 and FGF4 which maintain 
the FGF10 signal and proliferation in the mesoderm (Fig 1.8 bottom) (Sun et al., 2002). 
The position of FGF10 expression is regulated by Wnt8c in the hindlimb and Wnt2b in 
the forelimb, belonging to the major class of secreted morphogenic ligands. The forelimb 
and the hindlimb are specified by their position along the anterior/posterior axis and by 
two T-box containing transcription factors, the  Tbx5 and Tbx4, respectively (Li et al., 
1997). 
The  Zone  of  Polarizing  Activity  (ZPA)  in  the  limb  bud  exhibit  a pattern-organizing 
activity via action of a morphogen gradient of Sonic hedgehog (Shh) (Fig. 1.7B). Shh is 
necessary  to  create  ZPA and  specify  the  anterior/posterior  pattern  in  the  distal  limb 
(Riddle et al., 1993). Shh is maintained in the posterior through a feedback loop between 
the ZPA and the AER (Fig. 1.8). Shh induces the AER to produce FGF4 and FGF8 which 
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maintain the expression of Shh. Digits 3, 4 and 5 are specified by a temporal gradient of 
Shh. Digit 2 is specified by a long-range diffusible form of Shh, however, Digit 1, the 
thumb, does not require Shh (Chiang et al., 2001). 
Figure 1.8: Proposed model for coordinated growth and patterning of the limb. Sonic hedgehog 
(Shh) signalling from the zone of polarizing activity (ZPA) induce the expression of Hoxd and 
Bmp2 genes in the mesoderm. However, the induction itself needs the signals from the apical 
ectodermal ridge (AER), i.e. the FGFs. In turn, the expression of FGFs can be induced by Shh 
and vice versa generating a positive feedback loop of the ZPA and AER. Additionally,  FGFs 
promote mesodermal  proliferation.  Thus,  the patterning and proliferation is  dependent  on the 
same  signals,  the  limb  patterning  and  outgrowth  are  inseperably connected  with  each  other. 
(Laufer et al., 1994, modified)
In order to separate the digits, programmed cell death is needed which removes the tissue 
between the digits and joints. The signaling of bone morphogenic proteins induces cell 
death while Noggin blocks cell death in this tissue (Capdevila et al., 1998). In summary, 
signals  directed from the ZPA and AER are highly  regulated and  dependent  on each 
other, connecting proliferation and morphogenic patterning (Fig. 1.8).
1.5.2 Contribution of bone morphogenic proteins (Bmp) to limb bud development 
and skeletogenesis
Bone morphogenic proteins (Bmps) play an important role in a variety of developmental 
processes, for example in early limb patterning as well as in skeletogenesis. They are 
secreted signalling molecules which belong to the transforming growth factor ß (TGFß) 
17
ZPA
AER
Sonic hedgehog
FGFs
Hoxd
Bmp-2
others
Proliferation
Pattern
                                                                                                                           Introduction  
superfamily (Reddi et al., 1972; Urist et al., 1965; Wozney et al., 1988). 
Bmp2, Bmp4 and Bmp7 are expressed in the early limb bud mesenchyme (Francis et al., 
1994; Yang et al., 1997) whereas only Bmp2 and Bmp7 are active downstream of Shh 
signalling (Bandyopadhyay et al., 2006) (see Fig. 1.8). Bmp4 appears not to be induced 
by Shh expression as seen in Shh deficient limb buds (Pizette et al., 2001). In contrast, 
the expression of Bmp2 and Bmp7 is diminished in the absence of Shh activity (Chiang 
et al., 1996). 
All three Bmps induce apoptosis of the interdigital spaces (Ganan et al., 1996; Yokouchi 
et  al.,  1999;  Zou  and  Niswander,  1996).  The  involvement  of  Bmps  in  fundamental 
developmental  processes  in  underlined  by  the  early  lethality  of  Bmp1  and  Bmp4 
deficient  mice  (Winnier  et  al.,  1995;  Zhang and Bradley,  1996).  Using a  conditional 
approach the role of these two molecules in the limb patterning could be determined 
(Bandyopadhyay et al., 2006). Bmp2 deficient limbs developed striking syndactylies with 
dramatically  reduced  apoptosis  between  the  digits,  whereas  the  digits  themselves 
developed normally (Bandyopadhyay et al., 2006). Application of Bmp antagonists leads 
to a block of apoptosis (Yokouchi et al., 1999; Zou and Niswander, 1996) suggesting that 
a threshold level of the Bmp signalling is necessary to efficiently induce programmed 
interdigital death. The impact of Bmp expression on skeletogenesis is well described. For 
instance, osteoblastic differentiation is diminished in Bmp2 and Bmp7 double deficient 
limbs whereas Bmp2, Bmp4 or Bmp7 alone did not show any skeletal or chondrogenic 
anomalies  (Bandyopadhyay  et  al.,  2006).  A  blockade  of  Bmp2  signalling  by  its 
antagonist  Noggin  in  chick  embryos  resulted  in  defective  formation  of  a  proposed 
ectodermal signaling center that regulates craniofacial patterning (Foppiano et al., 2007). 
Similar anomalies in craniofacial development could be seen when Shh signalling was 
diminished  in vivo. The inhibition of Shh pathway was achieved by an alkaloid called 
cyclopamine in a cultured mouse (Nagase et al., 2005) or chick embryo (Cordero et al., 
2004) or other teratogens such as alcohol or retinoids (Cohen an Shiota, 2002) where also 
a reduction of Bmp signalling is expected. However, an involvement of Bmp signalling 
in holoprosencephaly (HPE),  a craniofacial  malformation in human associated with a 
disturbed Shh signalling, was recently described (Fernandes et al., 2007). In summary, 
the  threshold  of  Bmp  signalling  is  important  in  many  developmental  processes, 
especially the limb formation and skeletogenesis. 
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1.5.3 The  impact  of  Cx43  containing  gap  junction  channels  on  morphogen  
expression
During chick limb development Cx43 is expressed in restricted domains in the apical 
ectodermal  ridge  (AER)  and  mesenchyme  of  the  zone  of  polarising  activity  (ZPA) 
(Makarenkova  et  al.,  1999).  Application  of  gel  beads  soaked  with  Cx43  antisense 
oligonucleotides at stages before limb outgrew resulted in obvious limb phenotypes such 
as truncation or fragmentation of the limb bud, or a complete splitting into two or three 
branches  (Makarenkova et  al.,  1999).  This  knock down of  Cx43 expression led  to  a 
drastic reduction of Shh and Bmp2 mRNA in situ. Others described a knock down of 
Cx43 in chick which resulted in limb patterning defects including deletion of the anterior 
digits (Law et al., 2002). Here both, Shh and Bmp2 were also clearly downregulated in 
treated limbs while expression of FGF8, Bmp4 or Muscle segment homeobox-like gene 
(Msx-1)  remained  unchanged.  Thus,  Cx43  mediated  gap  junctional  signalling  or 
expression is required for chick limb development.  Also a modulation of chondrogenic 
differentiation in vitro by Bmp2 involves gap junctional coupling. The inhibition of gap 
junction mediated intercellular communication by 18 alpha glycerrhetinic acid decreased 
chondrogenic differentation by 50% 96 h after plating while the inhibition during the first 
24-48 h, a critical initial phase of condensation, did not have any effects (Zhang et al., 
2002). This suggests that gap junctional coupling is not critical for the initiation but plays 
important roles in the continuation of chondrogenesis, a process in which Bmp signalling 
is  crucial.  In  contrast,  gap  junctional  communication  has  also  been  described  to  be 
modified by Bmp2 and Bmp4 in P19 cells,  an embryonic carcinoma cell  line (Bani-
Yaghoub  et  al.,  2000).  Cells  treated  with  Bmp2  or  Bmp4  lose  their  capacity  to 
differentiate into neurons and maintain extensively coupled by gap junctions.  Recently, 
an endogenous blockade of Shh signalling in the developing midbrain has been proposed 
to be mediated by gap junctions preventing radial columns of cells from differentiation 
(Bayly  et  al.,  2007).  This  inhibition  is  discussed  to  be  achieved  by  an  intercellular 
propagation via gap junctions of pro-vitamin D3 and subsequent secretion (Bijlsma et al., 
2006). The release of these small inhibitory molecules is dependent on Patched and takes 
place after Shh binding to its receptor. Thus, Cx43 function seems to modify and to be 
modified by Shh and Bmp2 cascades in diverse tissues and developmental stages. 
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1.6 Mouse as model for human disease
Transgenic are suitable models for genetic human diseases, primarily because their genes 
show a high degree of homology with man. 
The  function  of  genes  in  general  can  be  determined in  two approaches:  the  gain  of 
function and the loss of function concept. The targeted insertion of gene mutations like 
deletions, resulting in so called knock-out mice, or in replacements, so called knock-in 
mice, are two major approaches in molecular genetics. Using reporter genes like green 
fluorescent protein (GFP) or ß-galactosidase driven by the promoter of the corresponding 
gene the expression of this gene can be localized to certain cells. 
Transgenic mice can be used to answer many central questions in biology like molecular 
reasons of human diseases giving the opportunity to develop new therapeutic agents and 
procedures. 
1.6.1 Targeted insertion of a conditional gene mutation
The insertion of a targeted gene mutation can be achieved by homologous recombination 
of the vector construct into the genome of mouse embryonic stem cells (Nagy et al., 
2003). These vectors include homologous sequences to the targeted gene which flank the 
sequence  to  be  inserted.  Once  the  vector  is  located  in  the  nucleus  of  the  cell  the 
homologous sequences in the vector can allign to the ones in the genome and recombine. 
These so called crossing-over events are highly infrequent with 10-6 to 10-7 depending on 
the targeted locus. After this in vitro manipulation ES cells are injected into the blastocyst 
allowing the generation of chimaeras and after matings with mice of homogenous genetic 
background, the generation of transgenic mice.
For conditional deletion or activation of genes the Cre/loxP- and Flp/frt-systemes can be 
used (Kühn et al., 1995). Cre is a recombinase derived from the P1 bacteriophage with a 
molecular mass of 38 kDa (Sternberg et al., 1986). Flp is the other common recombinase 
in  molecular  genetics  which  has  a  similar  size  but  was  derived  from  the  yeast 
Saccharomyces cerevisae (Buchholz et al., 1998). Both enzymes consist of two different 
subunits and are not dependent on any cofactor  (Lewandoski et al., 2001). Cre and Flp 
recombinases recognize and bind to their specific sites: loxP sites in the case of Cre and 
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frt sites in the case of Flp. The core sequences in both recognition sites determine their 
orientation (Fig.  1.9A).  If both sites are orientated in the same direction,  the flanked 
sequence will  be deleted and one loxP site  remains  (Fig.  1.9B).  If  the sites point  in 
different directions, the flanked sequenced will be inverted. 
Figure 1.9: Schematic illustration of the cre/loxP and FLP/frt recombination system. (A) The 34 
bp loxP and frt sites consist both of two inverted 13 bp repeats and an asymmetric 8 bp core 
sequence determining its orientation. (B) Cre or Flp recombinase dimers bind to their recognition 
sites and mediate the excision of the target DNA sequence in between the loxP or frt sites, if both 
sites have the same orientation. (Lewandoski, 2001)
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1.6.2 The Cx43G138R targeting vector for conditional replacement of Cx43 in  
mice
The  targeting  vector  mCx43ODDD-KI  vector  was  generated  and  used  during  my 
diploma thesis (2004) for the targeted replacement of the endogenous Cx43 wild-type 
gene in mouse embryonic stem (ES) cells (Fig. 1.10). The vector contains 5' (4.9kb) and 
3' (1kb) homologous regions which are needed for the targeted recombination in ES cells, 
the floxed region (black arrows in Fig. 1.10) that consists of the Cx43 wild-type coding 
DNA as well as the PGK-neomycin selection cassette (phoshoglycerate kinase promoter 
with neomycin resistance gene) which in turn is flanked by frt sites (green arrows in Fig. 
1.10). After Flp mediated recombination the PGK-neomycin cassettes can be deleted. 
Both  loxP sites  were  positioned  within  intron  sequences  to  avoid  any  reduction  in 
transcription of the wild-type gene. In addition, the flirted PGK-neo box was integrated 
in inverse orientation to the Cx43 coding region which minimizes disturbances of the 
Cx43 promoter by the strong PGK promoter driving neomycin resistance. Additionally, 
an ectopic reporter gene expression by a read through of the selection gene could be 
avoided. 
After a Cre mediated recombination the vector effects the transcription of the mutated 
Cx43G138R  gene,  the  internal  rebosomal  entry  site  (IRES,  Attal  et  al.,  1999)  and 
enhanced green fluorescent protein (eGFP). This combination of gene cassettes allows 
the expression of the mutated Cx43 protein and the reporter eGFP without affecting the 
properties  of  the  mutated  protein  as  described  for  some  GFP fusion  proteins.  The 
expression of an in vivo reporter gene such as GFP allows the detection of Cx43G138R 
localization in  living and fixated mouse tissues.  This  is  important  because the point-
mutated and the wild-type genes cannot be distinguished from each other in antibody-
based assays. 
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Figure 1.10: The conditional mouse Cx43G138R vector. The 5' and 3' homologous regions flank 
the entire region to recombine into the genomic locus of Cx43 in mouse ES cells. The floxed 
region which can be removed after a cre mediated recombination contains the wild-type Cx43 
gene  and  the  PGK-neomycin  resistance  cassettes  which  again  were  flanked  by  frt  sites. 
Downstream of the last loxP site Cx43G138R gene followed by the internal ribosomal entry site 
(IRES) and enhanced green fluorescent protein (eGFP) are coded. This order of gene cassettes 
allows  the  translation  of  the  mutated  Cx43  protein  and  eGFP  from  one  long,  bicistronic 
messenger RNA connecting the expression of the two genes and avoiding possible disturbances 
of the mutated protein as known for some GFP fusion proteins (R. Dobrowolski, Diploma thesis, 
2004). 
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1.7 Aims of the study
The  GJA1  gene encodes  the  human Connexin  43 (Cx43)  protein,  the  best  described 
member  of  the  connexin  gene  family.  Mutations  in  Cx43  cause  oculodentodigital 
dysplasia (ODDD), a rare pleiotropic human disorder (Paznekas et al., 2003). 
The main goal of this study was to explore the molecular mechanisms underlying ODDD 
and the impact on gap junction channel and hemichannel function in the Cx43G138R 
mutation causing this  disorder.  In order  to  investigate  this  mutation  in  vivo  a mouse 
targeting vector was cloned during my diploma thesis and used for transfection of mouse 
embryonic  stem  (ES)  cells.  ES  cell  clones  which  had  undergone  homologous 
recombination  had  to  be  identified  and  used  for  generation  of  mice  conditionally 
expressing  the  Cx43G138R  mutation.  Furthermore,  recombinant  ES  cells  after  cre 
transduction as well as HeLa and primary cells had to be used for the characterization of 
molecular consequences of Cx43G138R expression. As reporter gene in this study eGFP 
allows to detect Cx43G138R expressing cells  in vivo and in vitro making it possible to 
assess primary cell cultures and prove the expression pattern of the mutated gene. 
The impact of the Cx43G138R mutation in mice had to be investigated after activation of 
the mutant gene using different cre expressing mice. Conditional expression in the heart 
or the brain would offer the opportunity to determine the effect of the mutation in certain 
tissue  at  a  certain  developmental  stage.  Furthermore,  the  occurrence  of  possible 
morphological  anomalies  and cardiac  function  described to  be altered in  one ODDD 
affected family should be characterized in the conditional Cx43G138R mouse mutant. 
Thus,  the  impact  of  this  Cx43  mutation  on  regulation,  phosphorylation  and  channel 
function in vivo and in vitro, as well as embryonic development and cardiac physiology 
had to be determined. 
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2. Material
If not specially mentioned in the methods chapter, solutions and materials were prepared 
in general as described previously in detail (Dobrowolski, 2004, diploma thesis; Degen, 
2003,  PhD  thesis).  Plasmids,  bacterial  strains,  eukaryotic  cell  lines,  mouse  strains, 
primers and antibodies utilized during this PhD thesis are listed below.
2.1 Plasmids
Plasmid Reference Properties
mCx43ODDD_KI Dobrowolski et al., 2008
Conditional Cx43floxG138R targeting 
vector, ampicillin and neomycin 
resistance
pGEM-T Easy Vector 
Promega, A1360 Ampicillin resistance
pMJ-green Maxeiner et al., 2005 
Eukaryotic expression vector,
ampicillin resistance
HeLaCx43G138R Dobrowolski et al., 2007
Eukaryotic expression vector, carrying 
the Cx43G138R point mutation 
ampicillin and zeocin resistance
HeLaCx43I31M Dobrowolski et al., 2007
Eukaryotic expression vector, carrying 
the Cx43I31M point mutation 
ampicillin and zeocin resistance
HeLaCx43I143S Dobrowolski et al., 2007
Eukaryotic expression vector, carrying 
the Cx43I143S point mutation 
ampicillin and zeocin resistance
HeLaCx43H194P Dobrowolski et al., 2007
Eukaryotic expression vector, carrying 
the Cx43H194P point mutation 
ampicillin and zeocin resistance
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2.2 Bacterial strains
Bacterial strain Reference Properties
XL-1 blue Bullock et al., 1987 tetracycline  resistance,  plasmid 
ampli-fication, α-complementation
Top10 Invitrogen plasmid amplification, α-comple-
mentation
2.3 Eukaryotic cell lines
Eukaryotic cell line Reference Annotations
HM1 mouse ES-cells Magin et al., 1992 mouse  embyonic  stem  cells, 
SV129/ola
HeLa wild-type Jones et al., 1971 Zervix-carcinoma derived cell line
HeLaCx43 Welcker, 2004, diploma 
thesis
stable Cx43 wild-type expression
HeLaCx43-eGFP Welcker, 2004, diploma 
thesis
stable  Cx43-eGFP fusion  protein 
expression
HeLaCx43G138R Dobrowolski et al., 2007 stable Cx43G138R expression
HeLaCx43I31M Dobrowolski et al., 2007 stable Cx43I31M expression
HeLaCx43I143S Dobrowolski et al., 2007 stable Cx43I143S expression
HeLaCx43H194P Dobrowolski et al., 2007 stable Cx43H194P expression
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2.4 Transgenic mouse strains
Transgenic mouse 
strain
Reference Application
PGK-Cre Lallemand et al., 1998 ubiquitous  Cre-mediated  deletion 
of  loxP  -sites  flanked  genes  in 
mice
αMyHC-Cre Agah et al., 1997 cardiomyocyte specific Cre-medi-
ated deletion of loxP -sites flanked 
genes in mice
Nestin-Cre Tronche et al., 1999 early  neuron  specific  Cre-
mediated  deletion  of  loxP  -sites 
flanked genes in mice
Cx43KILacZ Theis et al., 2001 replacement  of  Cx43  coding 
region  by  LacZ  reporter  coding 
DNA
Cx43KICFP Degen et al., not yet 
published
replacement  of  Cx43  coding 
region  by  CFP  reporter  coding 
DNA
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2.5 Primers
2.5.1 Primers for mice genotyping
Primer Sequence (in 5'-3' direction)
Vor_poly A GGGGGTGAAGGAGTTTTCAGCAGTGC
In_kod_Reg.Cx43 GCTTCCCCAAGGCGCTCCAGTCACCC
Vor_LoxP GCACTTGGTAGGTAGAGCCTGTCAGGTC
UP-IntCre TTTGCCTGCATTACCGGTCGATGC
IntCre-rev TCCATGAGTGAACGAACCTGGTCG
43del_for GGCATACAGACCCTTGGACTCC
43del_rev TGCGGGCCTCTTCGCTATTACG
PGK1 GCTGTTCTCCTCTTCCTCATCTCC
Nestin TCCCTTCTCTAGTGCTCCACGTCC
MHC5P ATGACAGACAGATCCCTCCTATCTCC
Cre3 CTCATCACTCGTTGCATCGAC
2.5.2 Primers for real-time RT-PCR analyses
Primer Sequence (in 5'-3' direction)
ß-actin_for ACGGCCAGGTCATCACTATTG
ß-actin_rev ATGGATGCCACAGGATTCCAT
GAPDH_for TCAACGACCCCTTCATTGAC
GAPDH_rev ATGCAGGGATGATGTTCTGG
Gli1_for TGGATATGATGGTTGGCAAGTG
Gli1_rev ACAGACTCAGGCTCAGGCTTCT
Gli2_for CACAGGGCGGGCACAAGAT
Gli2_rev GGAGGGCAGTGTCAAGGAA
Shh_for CGGCAGATATGAAGGGAAGA
Shh_rev GGTCCAGGAAGGTGAGGAAGT
β-catenin_for TCTACGCCATCACGACAC
β-catenin_rev CAGACAGACAGCACCTTC
MmBmp2_for TGCGCAGCTTCCATCACGAA
MmBmp2_rev GTGAGAAACTCGTCACTGGG
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2.6 Antibodies
2.6.1 Primary antibodies
Primary antibody Reference/Company Species/Order No. Dilution
anti-Cx30 Zymed Rabbit/71-2200 1:500
anti-Cx40 Alpha Diagnostics rabbit/Cx40-A 1:150
anti-Cx43 Traub et al., 1994 rabbit 1:500
anti-Cx43 Zymed mouse/35-5000 1:300
anti-Cx43 Sigma rabbit/C6129 1:1000
anti-Cx45 Dedek et al., 2006 rabbit 1:750
anti-NeuN Chemicon mouse/MAB377 1:1000
anti-Nestin Chemicon Mouse/MAB353 1:1000
anti-GFAP Sigma mouse/G-3893 1:1000
anti-EGFP Abcam rabbit/Ab290 1:1000
anti-EGFP Abcam chicken/Ab13970 1:500
anti-ß-galactosidase Sigma mouse/G-8021 1:1000
anti-ß-actin Sigma mouse/A4700 1:500
anti-Bmp2 Abcam rabbit/Ab14933 1:300
anti-Bmp2 SantaCruz goat/sc-6895 1:100
anti-Bmp4 Abcam rabbit/Ab18865 1:300
anti-Noggin RnD Systems goat/AF719 1:500
anti-FGF8 RnD Systems mouse/MAB323 1:500
anti-Shh RnD Systems goat/AF464 1:500
anti-Shh SantaCruz goat/sc-1194 1:150
anti-Oct3/4 SantaCruz mouse/sc-5279 1:1000
anti-Vimentin Progen Biotechnik guinea pig/GP53 1:100
anti-MECA-32 PharMingen rat/09921D 1:200
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2.6.2 Secondary antibodies
Secondary antibody Reference/Company Order No. Dilution
Alexa(594)-goat anti-rabbit Molecular Probes A-11037 1:1000
Alexa(488)-goat anti-mouse Molecular Probes A-11029 1:1000
Alexa(488)-goat anti-rabbit Molecular Probes A-11008 1:1000
Cy2-goat anti-chicken Dianova 103-225-155 1:1000
Cy3-donkey anti-mouse Dianova 715-165-151 1:1000
Cy3-donkey anti-rabbit Dianova 711-165-152 1:1000
Cy5-donkey anti-mouse Dianova 115-175-166 1:1000
Cy3-goat anti-guinea pig Jackson ImmunoResearch 106-165-003 1:1000
HRP-goat anti-mouse Dianova 111-035-144 1:15000
HRP-goat anti-rabbit Dianova 115-035-146 1:15000
Alkaline phosphatase-goat 
anti-rabbit
Pierce 31340 1:15000
Biotin-goat anti-rabbit Zymed 81-6140 1:5000
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3. Methods
If not specially mentioned, all standard laboratory methods were performed in general as 
previously described (Dobrowolski, 2004, diploma thesis; Degen, 2003, PhD thesis).
3.1 Generation and analysis of Cx43G138R conditionally expressing mice
3.1.1 Generation,  genotyping  and  Northern  blot  analysis  of  Cx43G138R  
transgenic mice 
The Cx43G138R mutation from a human patient (Paznekas et al., 2003) was inserted by 
PCR mutagenesis in the corresponding mouse gene, cloned into the pBluescript vector 
and sequenced in both directions by AGOWA (Berlin, Germany) as already described in 
my diploma thesis. For the screening of ES cell clones for homologous recombination the 
targeting  vector  DNA (150  mg) was linearized  by  NotI  digestion  and transfected  by 
electroporation (800 V and 3  mF) into murine ES cells  (HM1) (Magin et  al.,  1992). 
Selection of vector containing cells was performed using 350  µg/ml G418 (Invitrogen, 
Karlsruhe,  Germany).  In  order  to  test  for  homologous recombination,  genomic  DNA 
from the ES cell  clones was processed for PCR analysis  using a 5' upstream primer, 
binding to  the eGFP sequence in the targeting vector (eGFP_rev),  and an external  3' 
downstream primer specific for the 30 region of Cx43 (Cx43_30HR). To exclude clones 
in which recombination occurred partially, a second PCR analysis was performed with 
cells positive in the first one. Here, we used primers annealing upstream of the 5' loxP 
site (Cx43/31for) and downstream behind it (Cx43/31rev). Clones found to be positive in 
both PCR analyses were tested by Southern blot hybridization. For this purpose, DNA 
from  the  PCR-positive  clones  was  digested  with  HincII  or  BamHI  (both  for  the 
hybridization with the internal probe) or  HindIII (external probe). After electrophoretic 
separation  on  agarose  gels,  blotting  onto  Hybond  N+ membranes  (Amersham 
Biosciences,  Buck,  UK)  and  ultraviolet  crosslinking  for  fixation,  hybridization  was 
performed under stringent conditions using the Quick Hyb solution (Stratagene, La Jolla, 
CA, USA) at 68°C for 1.5 h. A 550 bp HincII fragment from the coding region of Cx43 
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was used as the internal probe and a 550 bp  AvaI fragment of the 3' homology region 
served as the external probe.
The homologously recombined ES cell clone was injected into C57BL/6 blastocysts, as 
described previously (Theis et al.,  2000). Blastocyst injections of ES cells resulted in 
mice, showing a high-degree fur-color chimerism, were afterwards mated with C57BL/6 
mice. Germline transmission of the recombinant allele was checked in agouti offspring 
by PCR analyses of isolated tail DNA. The heterozygous Cx43+/floxG138R mice were 
backcrossed with C57BL/6 mice to increase the C57BL/6 genetic background and mated 
to PGK-Cre (Lallemand et al., 1998), alphaMyHC-Cre (Agah et al., 1997) or Nestin-Cre 
(Tronche et al., 1999) expressing mice for deletion of the floxed Cx43WT coding DNA 
and  activation  of  the  Cx43G138R allele  ubiquitously,  in  cardiomyocytes  or  in  early 
neurons, respectively. 
To check for recombination after exposure to Cre-recombinase activity, BamHI digestion 
and hybridization with the internal probe were performed as described for screening of 
ES cell clones. 
Genotyping was performed by the PCR analysis using primers flanking the 5'  upstream 
loxP site  (primer1_loxP and  primer2_Cx43).  All  experiments  were  carried  out  with 
littermates of 87.5 % C57BL/6 genetic background. 
For Northern blot hybridization hearts and brains from transgenic and control mice were 
collected  in  liquid  nitrogen.  Total  RNA was  extracted  using  TRIZOL  (Invitrogen, 
Carlsbad,  USA),  following  the  instructions  of  the  manufacturer.  Twenty  micrograms 
were electrophoretically separated, blotted and hybridized as described (Hannemann et 
al., 1992). The same 550 bp HincII fragment of the Cx43 coding region that was used for 
Southern blot hybridizations was also applied for Northern blot hybridization.
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3.1.2 Morphologic abnormalities in Cx43G138R heterozygous mice equal those in 
ODDD patients
For recording of syndactylies, malformations of teeth and fur mutant and control mice 
were anesthetized and photographed using a Kodak 5 Megapixel camera.
Comparative  analyses  of  skull  bones  were  performed  using  skulls  from mutant  and 
control mice of 3 weeks and 6 months of age. The skin, the brain and most of the flesh 
were removed. Then, the skulls were incubated with maggots cultures over night. The 
remaining tissue was removed carefully, and the skull bones were cleared in a 13 % H2O2 
solution for 5–10 min.
3.1.3 Bone and cardiac morphology of Cx43 +/G138R mice
Hearts  investigated  in  the  electrophysiological  studies  were  fixed  in  4  % 
paraformaldehyde for 24 h at 48 °C, dehydrated and embedded in paraffin. The 3  mm 
thick sections were dried, deparaffinized with xylene,  hydrated in a dilution series of 
ethanol,  stained with hematoxylin/eosin,  treated with xylene and mounted in Entellan 
(Merck, Hohenbrunn, Germany). For bone analyses, tibiae were dissected and fixed in 10 
% formalin, decalcified in 14 % EDTA for 14 days and embedded in paraffin. Sections 
were stained with hematoxylin/eosin. Quantitative histomorphometry was performed in 
an area 175–875 mm distal to the growth plate using the OsteoMeasure software program 
(Osteometrix, Atlanta, GA, USA) in an epifluorescence microscopic system, as detailed 
(Castro  et  al.,  2004)  elsewhere.  The  following  parameters  of  bone  remodeling  were 
estimated:  trabecular  bone  volume  as  a  percentage  of  total  tissue  volume  (BV/TV), 
trabecular  separation  (Trabec.Sp.  in  micrometers)  and  osteoblast  perimeter  per  bone 
surface (Ob.Pm/BS. in percent).
3.1.3.1 Tissue preparation, fixation and sectioning
Hearts or brains were frozen in liquid nitrogen and embedded in Tissue Tec (Miles Inc., 
OH, USA) for cryostat sectioning. The sections (9  mm) were dried on air, fixed with 
absolute ethanol for 5 min, washed three times with PBS-, blocked in 4 % bovine serum 
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albumin (Sigma Aldrich, Steinheim, Germany) for 30 min and incubated with rabbit anti-
Cx43 serum (Wilgenbus et al., 1992) in blocking solution for 1 h. After washing with 
blocking  solution,  the  specimen  were  incubated  for  50  min  with  goat  anti-rabbit 
antibodies conjugated with Alexa 594 (1:2000 in blocking solution; MoBiTec, Göttingen, 
Germany) followed. After an additional washing step, the sections were embedded in 
Permaflour and analyzed with a Laser Scanning Microscope (LSM Axioplan 2; Zeiss, 
Germany).
3.1.4 Immunoblot analysis and immunoprecipitation
Hearts, brains or HeLa cells were solubilized in RIPA buffer and 1x Complete (Roche, 
Mannheim, Germany) and sonicated three times for 10 s during incubation on ice. For 
immunoprecipitation, rabbit Cx43 serum (1:1000 in blocking solution) (Wilgenbus et al., 
1992) was incubated with 10 ml protein A–Sepharose beads (Amersham Bioscience) for 
30 min  at  4°C.  Three  hundred  and fifty  microgram protein  were  incubated  with  the 
antibodies–bead complexes for 1.5 h at 4°C and washed three times with RIPA washing 
buffer for 10 min. For immunoblotting, the total protein was separated in SDS–PAGE 
and blotted onto Hybond ECL membrane (Amersham Bioscience). After blocking with 5 
% milk powder in washing buffer (8.5 mM Tris– HCl, 1.7 mM Tris-base, 50 mM NaCl, 
0.1 % Tween-20) for 1 h at room temperature, a 1 h incubation was performed with rabbit 
Cx43 antibodies (1:2000 in blocking solution) and a 45 min incubation with goat anti-
rabbit horseradish peroxidase (HRP)-conjugated antibodies (1:25000 Dianova, Hamburg, 
Germany),  with  three  wash  steps  in-between  and  afterwards.  The  membranes  were 
incubated  with  enhanced  chemiluminescence  reagents  (Amersham  Bioscience)  and 
developed on X-ray films.
3.1.5 The Cx43G138R mutation frequently results in premature death because of 
cardiac expression
Genotype statistics for progeny from heterozygous Cx43floxG138R mice after mating 
with PGK-, alphaMyHC- or Nestin-Cre mice were calculated using Microsoft Excel. In 
the case of PGK-Cre mice mating n = 32 litters were genotyped and counted out. For the 
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conditional  activation  of  the  Cx43G138R  mutation  in  the  heart  (alpha-MyHC-Cre 
mating) n = 29 matings and for the activation of the mutation in early neurons n = 15 
matings were used for the statistical evaluation. 
3.1.6 Cardiac function in cardiac specific Cx43G138R mutants
All cardiological analyses were performed in cooperation with  Dr. Philipp Sasse and 
Prof. Dr. Bernd Fleischmann from the Institute of Physiology I, University of Bonn, Dr. 
Jan W. Schrickel and Prof. Dr. Thorsten Lewalter, Dr. Alexander Ghanem, Dr. Clemens 
Troatz and  PD Dr. Klaus Tiemann for the Medical Clinic and Polyclinic, University of 
Bonn.
3.1.6.1 Electrophysiological examination and Langendorff measurements
All electrophysiological in vivo measurements were carried out as previously described 
(van Rijen et al., 2004). For evaluation of ex vivo myocardial conduction velocities and 
characteristics,  hearts  were  Langendorff-perfused,  and  epicardial  activation  mapping 
(EAM) was performed using a 128-electrode array. Hearts were excorporated, dissected 
from surrounding tissue in ice-cold Krebs–Henseleit buffer and retrogradely perfused in a 
Langendorff  apparatus  (Radnoti  Technologies  Inc.,  Monrovia,  CA,  USA)  at  constant 
pressure (80 mmHg). The perfusate composition was (in millimolar): NaCl 110, KCl 4.6, 
MgSO4 1.2, CaCl2, NaH2PO4 2, NaHCO3 25, glucose 8.3, Na-pyruvate 2 and gassed with 
carbogen (O2 95 %, CO2 5 %), pH, 7.3–7.45 at constant 37 °C. 
Under  normal  perfusion conditions,  all  hearts  started beating spontaneously.  Hundred 
twenty-eight  unipolar  extracellular  electrograms  were  recorded  from  the  epicardial 
surface of the left ventricle using a custommade electrode array. Interelectrode distance 
was 300+7  mm. Unipolar electrograms were recorded using a 128 channel computer-
assisted  recording  system  (Multi  Channel  Systems,  Reutlingen,  Germany),  with  a 
sampling rate of up to 25 kHz. Data were bandpass-filtered (50 Hz), digitized with 12 bit 
and a range of 20 mV. 
Activation maps were calculated from these data using custom-made software (Labview 
7.1,  National  Instruments,  Austin,  TX,  USA).  The  first  derivative  of  each  unipolar 
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electrogram was evaluated, and the maximal negative dV/dt  activation was defined as 
time point of local activation in these mappings, as described before (van Rijen et al., 
2004;  Lammers  et  al.,  1990;  Li  et  al.,  1999).  Color-coded mapping indicated  in  red 
earliest activated and in blue the latest activated areas during heart beat.
3.1.6.2 In vivo recordings of electrocardiograms and hypoxic stimulation
For  in vivo ECG recordings, each animal was placed in a small apparatus (ECG tube, 
QRS Phenotyping Inc.,  Calgary,  Canada),  where the feet had contact to gel electrode 
pads (Hesse et al., 2007). ECG waves and intervals were measured with a PowerLab 26T 
device  (ADInstruments,  Colorado  Springs)  and  tabulated  using  a  pattern  recognition 
program (Chart 5 Pro ADInstruments). For hypoxic stimulation in vivo, the animals were 
placed into the ECG tube, anesthetized with 0.5 % isoflurane and exposed to hypoxic 
(hypoxia = gas  mixture of  5–10 % O2 with  95–90 % argon) for 2 min or  normoxic 
conditions.
3.1.6.3 Echocardiography
High-resolution echocardiography was performed using an ultrasound system equipped 
with a linear array transducer operating at an emission frequency of 15 MHz (harmonic-
mode)  with  frame  rates  up  to  280  Hz  (HDI-5000,  Philips  Medical  Systems).  Axial 
resolution was about 100 μm. 
Because ubiquitous and cardiac-specific mutants showed in contrast to wild-type mice a 
high lethality during isoflurane or sevoflurane anesthesia following standard protocols 
were administered for sedation at a constant body temperature (37°C): ketamine (10 mg/
kg weight) with disoprivan (0.05 mg/kg weight). Data sets were obtained as previously 
described (Tiemann et al., 2003; Ghanem et al., 2006). 
Heart frequency, left ventricular muscle mass, left ventricular end-diastolic volume and 
left  ventricular  ejection  fraction were  measured.  Parasternal  short-axis  views  were 
visually  divided  into  six  segments.  Imaging  was  considered  adequate  when  the 
endocardial and epicardial borders could be properly visualized in at least five segments. 
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End-diastolic  measurements  were  obtained  at  the  peak  of  the  R-wave,  whereas  end-
systolic  measurements  were  obtained  at  the  time  of  minimum  internal  chamber 
dimensions. 
3.2 Analysis of Cx43-/G138R hemizygously mutated mice
3.2.1 Simultaneous detection GFP and LacZ in mice tissues
The simulataneous detection of  eGFP (reporter  gene in the Cx43G138R mutant)  and 
LacZ (reporter  gene  in  the  Cx43LacZ  mutant)  gene  products  was  performed  in 
immunofluorescence  analyses  of  brain  and  heart  thick  slices.  The  animals  were 
anesthetized  with  Rompun (0.2 %)  and Ketavet  (0.5  %) (10  ml/kg),  thereafter  1  ml 
Heparin (Roche, Manncheim) was injected into the left ventricle of the mouse to avoid 
blood clots. Using the same condition 10 ml PBS- were applied, whereas the right atrium 
was transsected to  wash out  the blood from the tissues.  Subsequently the mice were 
transcardially perfused with 50 ml 4 % PFA/PBS-. The brains and hearts were isolated 
and  postfixed  at  4  °C  overnight  with  4  %  PFA/PBS- and  sectioned  with  a  Leica 
microtome  in  60  μm  slices.  For  ß-galactosidase,  GFP,  GFAP  and  NeuN 
immunofluorescence  analyses  floating  slices  were  washed  three  times  for  10  min  in 
PBS-/0.1  % Triton  X-100,  blocked for  2  h  at  room temperature  in  washing solution 
containing 2 % normal goat serum and incubated overnight at 4 °C with a mixture of 
primary antibodies diluted in blocking solution. The slices were washed three times and 
were incubated for 2 h at room temperature with the appropriate secondary antibodies 
diluted in blocking solution and washed again. The appropriate antibodies are listed in 
the Material chapter (2.6). Cover slips were mounted with Permafluor aqueous mounting 
solution  (Immunotech, Marseille, France). Immunofluorescence signals were visualized 
using a confocal Zeiss LSM510 microscope.
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3.2.2 Analyses of apoptosis in interdigital spaces
TUNEL assays  (Roche,  Mannheim,  Germany)  were performed on 12 µm thick cryo-
slices for detection of apoptotic cells between the developing digits in paws from ED 
12.5 and 13.5 old embryos following the instructions of manufacturer. 
3.2.3 Expression of diverse morphogens during development of limb bud
Diverse morphogens were detected in situ by immunohistochemistry staining of whole 
mount embryos following the adapted protocol from Dent et al. (1989) and LeMotte et al. 
(1989). 
Cx43 +/del female mice were mated with Cx43 del/G138R males. Pregnant females were 
prepared, embryos were collected in PBS- and yolk sacs were used for DNA isolation and 
genotyping.  Embryos  were  fixed  in  freshly  prepared  methanol/DMSO  (4:1)  at  4°C 
overnight. For blocking endogenous peroxidase activities the embryos were transferred 
into methanol/DMSO/H2O2 (4:1:1) solution for 5-10 hours at room temperature. At this 
point the supplements can be stored in 100 % methanol at -20 °C for several months. All 
following steps were carried out in siliconized microtubes. The preparations need to be 
rehydrated in 50% methanol, PBS- and twice PBS- with 2 % nonfat instant milk and 0.5 
% Triton  X-100  (PBSMT)  for  30  min  with  rocking,  respectively.  The  primary  and 
secondary antibodies are applied in PBSMT at 4 °C overnight consecutively and washed 
five times with PBSMT after their incubation as follows: once with 1 ml for 1 hour at 4 
°C,  one  with  10  ml  for  1  hour  at  4  °C ,  three  times  in  10  ml  for  1  hour  at  room 
temperature.  The supplements  are  rinsed in  PBS- with  0.2 % BSA and 0.5 % Triton 
X-100 (PBT) two times (once with 5 ml and once with 1 ml) for 20 min, respectively. 
The  staining  is  achieved  with  DAB/NiCl2 or  Histogreen  reagent  (Linaris,  Wertheim-
Bettingen,  Germany)  and  H2O2 to  a  0.03  %  final  concentration  for  2-10  min. The 
supplements were photographed directly after staining
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3.2.4 Real-time RT-PCR analyses
RNA was obtained from ED 11.5, 12.5, 13.5 and 14.5 old mutant and control embryonic 
limb buds after dissection using the RNeasy kit (Quiagen, Hilden, Germany). Reverse 
transcription of RNA was performed according to Söhl et al. (1998). One twentieth of the 
transcribed cDNA was amplified by PCR. The reaction was performed using 20  μl of 
total reaction mixture volume, containing 1 μl of cDNA reaction products and 0.2 μl of 
SYBR Green I as follows: one cycle at 95 °C for 10 min, followed by 40 amplification 
cycles, each cycle consisting of denaturation at 95 °C for 30 s, primer annealing at 59 °C 
for 30 s and extension at 72 °C for 30 s. Alterations were determined based on average 
cycle threshold values for duplicates.  
3.2.5 Limb bud cultures
For assessment of limb bud cultures ED 11.5 and ED14.5 embryos were dissected from 
pregnant female mice, the limb buds were removed, fragmentated and digested with a 
collagenase/trypsin  (3:1)  solution  for  20  min  at  37  °C.  The  enzyme  solution  was 
discarded and tissue fragments collected at the bottom of the tube. The primary cells 
were separated  by pipetting  of  300 µl  primary cell  culture  medium as  described  for 
cardiomyocyte  cultures  (Herr  et  al.,  2001).  After  an  incubation  for  30  min  at  room 
temperature with rocking the cells were seeded onto cover slips for immunofluorescence 
analyses, standard cell culture dishes for Western blot lysates or ibidi µ-dishes® (ibidi, 
Martinsried, Germany) for calcium imaging. 
3.2.6 Immunofluorescence analyses of limb bud cultures
Limb bud cells from wild-type, Cx43 LacZ/G138R and Cx43 LacZ/LacZ embryos grown 
on glass cover slips to a confluence of 70 %-100 % were fixed in 4 % PFA, washed in 
PBS- and preincubated for 1 h in blocking reagent (PBS- containing 5 % NGS). All slides 
were incubated overnight at 4 °C with polyclonal anti-Cx43 (1:500, Traub et al., 1994), 
anti-Oct3/4 (Santa  Cruz,  CA),  Vimentin  (Progen Biotechnik),  Shh (RnD Systems)  or 
Bmp2 (RnD Systems) antibodies. The localization of the proteins was visualized using 
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the  following  secondary  antibodies:  Alexa(488)-goat  anti-rabbit  (Molecular  Probes), 
Cy5-donkey  anti-mouse  (Dianova)  or  Cy3-goat  anti-guinea  pig  (Jackson 
ImmunoResearch).
Cover  slips  were  washed in  PBS- and  mounted  with  the  aqueous  mounting  medium 
Permaflour  (Immunotech,  Marseille, France). Fluorescent signals were recorded using 
Zeiss LSM510 confocal microscope. 
3.2.7 Calcium imaging
The imaging of calcium concentrations in living cells was performed in cooperation with 
Dr. Hartmann Harz (Bioimaging Zentrum, University of Munich). 
The  calcium  imaging  technique  allows  to  detect  changes  in  intracellular  calcium 
concentration with high temporal and spatial resolution. Here, fluorescence microscopy 
with  a  CCD-camera  and image processing were  combined.  In  order  to  measure  free 
intracellular  calcium ions  fluorescent,  polycyclic  chelate  molecules  were  used  which 
change their fluorescence properties in Ca2+ bonded or Ca2+ unbonded state. These Ca2+ 
indicators can be divided into such shifting their excitation and emission spectra (for 
example Fura-2 or Indo-1) or such increasing their fluorescence ability after binding to 
Ca2+ (for  example   Fluo-4,  Calcium  Orange,  Calcium  Crimson).  The  diverse  Ca2+ 
indicators  show different  Ca2+ binding  affinities.  Indicators  with  a  high  affinitiy  are: 
Fura-2, Fluo-4, Indo-1, whereas Fluo-4FF, Fluo-5N, Calcium Crimson show relative low 
affinities  for  Ca2+ ions.  The  dissociation  constant  (KD)  of  each  indicator  assigns  the 
concentration range in which it should be used. 
For  Ca2+ visualization  during  this  PhD  work  the  indicator  Fura-2AM  was  used  to 
determine high Ca2+ concentrations. The acetoxymethyl(AM)-ester group coupled to the 
Fura  molecule  is  hydrophobic  and  uncharged,  thus,  could  pass  through  the  plasma 
membrane. In the cytosolic compartment of the cell the AM group can be cleaved by 
unspecific  esterases.  After  cleavage  the  indicator  is  negatively  charged  and  cannot 
penetrate through the plasma membrane and therefore stays in the cytosol. 
The  changes  of  intracellular  Ca2+ concentration  can  be  recorded  as  changes  in 
fluorescence intensities which were converted into false color images by the associated 
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computer software. Low Ca2+  concentrations were indicated in dark blue, whereas high 
concentrations were displayed in bright red colors. A pile of images can be recorded 
during one experiment and can be processed and calculated with  the associated imaging 
software. Thus, images from one experiment can be arranged into a movie showing the 
temporal  change  of  Ca2+ concentration  in  cultured  cells.  Also  kinetics  of  regions  of 
interest, i.e. cells can be assessed.
3.3 In vitro analyses of the Cx43G138R and other ODDD associated Cx43 
mutations
HeLa cells were stably transfected with a vector containing the Cx43G138R-IRES-eGFP 
cassettes  or  the  Cx43-coding  DNA driven  by  a  CMV promoter  for  overexpression. 
Double  transfectants  were  generated  by  stable  transfection  of  Cx43  expressing  cells 
(Traub  et  al.,  1994)  with  the  Cx43G138R  vector.  The  recombinant  ES  cells  were 
generated  by  homologous  recombination,  as  described  earlier.  To  express  the 
Cx43G138R protein, the ES cells were transduced with Cre protein and subcloned, as 
previously  described  (Nolden  et  al.,  2006).  The  cardiomyocytes  were  derived  from 
Cx43+/floxG138R:alphaMyHC-Cre and for controls from Cx43+/floxG138R ventricles 
of embryonic hearts on ED 12.5 and ED 16.5, as described previously (Herr et al., 2001). 
Each heart was dissociated and plated separately; its genotype was identified by green 
fluorescent protein and proven by PCR of the remaining embryonic tissue.
3.3.1 Tracer  coupling  of  Cx43G138R  expressing  cells  and  electrophysiological  
measurements of Cx43G138R channels
All tested cells were microinjected by iontophoresis with neurobiotin at confluency. In 
the case of embryonic cardiomyocytes, the peripheral cells of beating cell clusters were 
injected. The cultures were fixed in a fresh 1 % glutaraldehyde in PBS- for 5 min, washed 
twice with PBS- and permeabilized with 2 % Triton X-100 for 2 h at room temperature. 
After washing with PBS-, the cells were incubated with HRP-conjugated avidinD (Vector 
Laboratories, Burlingame, CA, USA) solution for 90 min, washed again and stained with 
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the HistoGreen POD substrate kit (Linaris, Wertheim- Bettingen, Germany), following 
manufacturer’s  instructions.  To  study  whether  heterotypic  Cx43G138R-Cx43WT 
channels are functional, Cx43G138R expressing HeLa cells and HeLa cells expressing 
Cx43WT-eGFP as a fusion protein were co-cultured. Cell pairs showing visible eGFP 
fluorescent plaques were identified and measured. Patch clamp protocols were used, as 
described previously (Kreuzberg et al., 2005).
3.3.2 ATP release and dye uptake studies
To  measure  the  activity  of  ATP-releasing  channels,  cells  were  incubated  in  500  ml 
modified Hank’s balanced salt solution (HBSS; Sigma Aldrich) with or without Ca2+, 
Mg2+ and additional 1 mM EGTA for 20 min at 37 °C. For hypoxic stimulation, the cells 
were incubated for 2 h in a hypoxic incubator (Herolab, Wiesloch, Germany). For ATP 
release experiments, 100 ml of the supernatant was collected and incubated with 100 ml 
nucleotide releasing reagent (ViaLight HS kit, Cambrex, Rockland, ME, USA) for 20 
min. The luciferase activity indicating ATP concentration was measured for 10 s with a 
Berthold  Microplate  LB96V  luminometer  after  addition  of  20  ml  ATP  monitoring 
reagent. The luminometric results were normalized to whole protein amount. In studies 
with HeLa transfected cells, the expression level of the mutant and the wild-type Cx43 
protein were determined by the immunoblot analysis. Expression of Cx43G138R was 
normalized by GFP fluorescence and protein amount.
Hypoxic  stimulation  of  hemichannels  was  also  performed  by  chemical  induction 
(chemical induced hypoxia, CIH) using KCN and NaI-acetate as recently described for 
gap junction full channels by Li et al. (2005). Because KCN also oxidizes luciferase, the 
assay could only be carried out with a saturated FeCl2 solution. By binding of the iron 
ions to the cyanide- generating the highly stable K4[Fe(CN)6] complex preventing the 
inactivation of luciferase (Fig. 3.1). 
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Figure 3.1: FeCl2 prevents the inactivation of luciferase by cyanide. Different amounts of the 
saturated FeCl2 solution were added to wells containing 0.5, 1 or 5 mM ATP for luciferase assay. 
FeCl2 inhibits the reaction (see the 16,7 µl FeCl2 bars). However, using 3.33 µl of the saturated 
FeCl2 solution  the  inhibition  is  negligible  and  the  cyanide  can  efficiently  be  complexed 
preventing the inactivation of luciferase (see the KCN + 3.33 µl FeCl2 columns). (RLU=relative 
luciferase units)
For dye uptake studies, ED 16.5 cardiomyocytes were incubated for 20 min in HBSS 
solutions  with  10  mM  propidium  iodide,  washed  twice  after  bathing,  fixed  in  4% 
paraformaldehyde  and  mounted  in  Permaflour  mounting  medium  (Immunotech, 
Marseille,  France).  The  propidium  iodide  fluorescence  was  detected  with  a  Zeiss 
microscope. To exclude all dead cells showing a weak fluorescence, only the number of 
pixels above a fixed threshold was used for further evaluation.
3.3.3 Contractions of cultured embryonic cardiomyocytes
The  beating  frequency  of  cultured  embryonic  cardiomyocytes  was  measured  after 
application of different drugs. Cells were exposed to FFA (50 mM, Sigma Aldrich) or the 
mimetic  peptide Gap26 (300  mM, Genscript,  USA) for 30 min at  37  °C.  Movies  of 
beating  cardiomyocytes  were  recorded  with  a  Sony  XCD-X710  (Koeln,  Germany) 
camera at 30 frames/s, and beating areas were analyzed off-line with a custom written 
software (Labview 7.1 and IMAQ, National Instruments). The number of pixels, which 
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change their intensity above a defined threshold in consecutive frames, increased with 
each beat. This was used to calculate interspike intervals that were averaged over at least 
20 s to obtain the average frequency.
3.3.4 Determination of the half-life of mutated and wild-type Cx43 proteins by  
pulse chase analyses
All proteins expressed by HeLa cells were radioactively labelled using 35S-methionine as 
described by Hertlein et al., 1998. After 4 h of incubation the medium was replaced by 
one containing non-radioactively labelled methionine. The cells were harvested in RIPA 
buffer directly or 2, 4, 6 or 8 h after labelling. The expressed connexin proteins were 
immunoprecipitated using anti-Cx43 antibodies coupled to protein A-Sepharose beads 
(Amersham Bioscience, Buck, U.K.) overnight. In order to avoid purification of proteins 
unspecifically binding to the Sepharose, the protein lysates were prehybridized with pure 
Sepharose  beads  before  immunoprecipitation.  On the  next  day the  protein  sepharose 
complexes were denaturated at 60 °C for 5 min and separated by SDS-PAGE. The gels 
were fixed in a solution containing 50 % methanol, 10 % acetic acid and 40 % water, 
incubated for 20 min in Amplify (Amersham, Bioscience, U.K.), dried and exposed for 
24  h  1  to  14  days.  The  resulting  bands  were  quantified  using  the  Herolab  software 
(Herolab, Wiesloch, Germany). For dosimetric evaluation the band intensities obtained 
without chase were defined as 100 %. The half life time of each mutated Cx43 protein 
was determined as the mean of at last 3 independent measurements using the GraphPad 
Prism software version 4.02. 
3.3.5 32P labeling of HeLa cells expressing Cx43G138R or wild-type Cx43
HeLa cells  cultured on 35 mM dishes  were incubated in  500  ml deficiency medium 
(Dulbecco’s  modified  Eagle’s  medium  without  L-glutamine  and  L-methionine  or 
phosphate, c.c.pro, Neustadt, Germany) for 1 h at 37 °C and afterwards with 50 mCi 32P 
ATP or 10 mCi 35S methionine per 105 cells in same medium for 4 h at 37 °C. The labeled 
cells were washed three times with PBS- and harvested in cold RIPA buffer (Degen et al., 
2004).
44
                                                                                                                                   Results  
4. Results
4.1 Generation and analysis of Cx43G138R conditionally expressing mice
In order to investigate the influence of Cx43G138R mutation in different tissues, mice 
were generated in which the cell type-specific activation of this mutated gene could be 
accomplished by Cre-recombinase-mediated deletion of the loxP flanked Cx43WT region 
(Fig.  4.1A  and  B).  The  Cre-recombinase  activity  led  to  the  expression  of  the 
Cx43G138R-internal ribosomal entry site (IRES)-eGFP cassettes (Fig. 4.1C) under the 
control of the endogenous Cx43 regulatory elements. 
Figure  4.1: Generation  of  the  conditionally  Cx43G138R  mutated  mice  by  homologous 
recombination (see next page). 
45
                                                                                                                                   Results  
(A) Homologous recombination of the targeting vector into the genomic locus of Cx43. (B) The 
resulting  recombinant  chromosome  corresponds  to  the  floxed  state.  (C)  After  Cre-mediated 
recombination, sequences between both loxP sites were excised resulting in the Cx43G138R gene 
expression. (D) Southern blot analysis indicating homologous recombination in mice. The 8484 
bp band is missing in the middle lane, demonstrating the deletion of loxP-flanked regions on the 
DNA. (E) Northern blot  analysis  indicates  the  conditional  transcription of the mutated Cx43 
construct in the heart,  but not in the brain after mating with alphaMyHC-Cre mice. (F) PCR 
genotyping using the primers as shown in A–C.
For the selection of vector containing HM1 embryonic stem (ES) cells, the neomycin 
resistance  gene,  flanked  by  frt  sites,  was  cloned  directly  after  the  polyA signal  of 
Cx43WT. 
One of 251 ES cell clones (= 0.4 %; clone no. 234) had undergone correct homologous 
recombination into the Cx43 locus, showed normal caryotype and was used for blastocyst 
injections.  The  integration  into  the  Cx43  locus  was  demonstrated  in  the  different 
genotypes  of  the  Cx43floxG138R  mouse  line  before  and  after  Cre-mediated 
recombination  (Fig.  4.1D).  The  Cx43+/floxG138R  mice  were  mated  with  PGK-, 
alphaMyHC- or Nestin-Cre-expressing mice for ubiquitous, cardiac myocyte- or early 
neuron-specific  activation  of  the  mutated  gene.  Furthermore,  the  cell  type-specific 
transcription  of  the  Cx43G138R-IRES-eGFP cassette,  as  a  long  4.4  kb  mRNA,  was 
found in heart but not in brain after the alphaMyHC-Cre activity (Fig. 4.1E). The mice 
were genotyped by polymerase chain reaction (PCR),  as shown in figure 4.1F, using 
primers (primer 1 and 2 in Fig. 4.1) flanking the first loxP site but binding to endogenous 
sequence.
4.1.1 Morphologic abnormalities in Cx43G138R heterozygous mice equal those in 
ODDD patients
The ubiquitous  and heterozygous expression of the Cx43G138R mutation resulted in 
mice exhibiting different ODDD characteristics with variable penetrance and appearance. 
The observed phenotypic manifestations were syndactyly in 70% (Fig. 4.2A–E), enamel 
hypoplasia in 80% (Fig. 4.2F and G), craniofacial abnormalities in 70% (Fig. 4.2H) and 
sparse hair in 30% (Fig. 4.2I) of all mutants. Syndactyly affected only the soft tissue 
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(type III syndactyly) (Fig. 4.2E) and was observed between the second, third and fourth 
digits on all limbs. The reduction of dental enamel was obvious as translucent teeth and 
their  faster  abrasion  with  age.  Furthermore,  the  craniofacial  anomalies  described  in 
ODDD  patients,  i.e.  the  prominent  and  depressed  nasal  bridge  and  microcephaly 
(Paznekas  et  al.,  2003),  could  largely  be  observed  in  the  Cx43+/G138R  mice.  The 
morphologic skull  analysis  of 3–9-week-old mutants (Fig.  4.2H) revealed an obvious 
compactness  of  the  facial  region  and differences  in  the  angle  of  the  nasal  bone,  the 
zygomatic arch, the eye pits and the size of the mandible, similar as reported in ODDD 
patients  (Paznekas  et  al.,  2003).  Sparse hair,  an infrequent  symptom of  ODDD, was 
rarely observed and became more pronounced in adult mice (Fig. 4.2I).
Figure 4.2: Morphological anomalies of the Cx43+/G138R ubiquitously expressing mice. (A–D) 
Syndactyly of all types. (E) Alcian blue and alizarin red staining for bones and cartilage indicates 
that  bones  are  not  affected  by  syndactyly.  (F  and  G)  Comparison  of  teeth  reveals  enamel 
hypoplasia  in  mutants  (G).  (H) Skull  bones  in  mutant  mice show significant  changes  in  the 
craniofacial regions (bottom). (I) Sparse hair could be observed in a small number of mutants but 
never in wild-type littermates.
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4.1.2 Bone morphology of Cx43+/G138R mice is similar to the one observed in  
ODDD patients
Hypoplasias of the phalages, broad tubular bones and hyperostosis of the skull have also 
been reported in patients with ODDD (Paznekas et al., 2003). In Cx43+/G138R mice, a 
significant  osteopenia  was observed.  Seven males  per  genotype  group were used for 
analysis. The results show significantly lower trabecular bone volume in ODDD relative 
to  wild-type  littermates,  indicating a  reduction  in  trabecular  bone mass.  Accordingly, 
trabecular spacing was increased and the number of osteoblasts  was not significantly 
decreased  in  the  mutant  mice  (Fig.  4.3),  even  though  trabecular  thickness  was  not 
different. In all mutants investigated, a high variability of this phenotype was observed.
Figure 4.3: Skeletal phenotype of the ODDD-mutated mice. Comparison of wild-type (A) and 
Cx43+/G138R (B) tibial epiphysis and metaphysis shows more rarefied trabecular structure in 
the ODDD mutant relative to a wild-type littermate. Histomorphometric analysis reveals lower 
bone volume/total volume (P=0.001) (C), an increase in trabecular space (P=0.01) (D) and a non-
significant (n.s.) decrease in osteoblast number (E) in mutants.
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4.1.3 The Cx43G138R mutation frequently results in premature death because of 
cardiac expression
The  matings  of  Cx43+/floxG138R  male  mice  with  PGK-Cre  female  mice  (n  =  32) 
yielded a reduction in the Mendelian ratio from 50 % to 23 % of mutants in a litter (Fig. 
4.4). The mutants were Cx43+/G138R:PGK-Cre (5%) and Cx43+/G138R (18%) because 
of the activity of active Cre protein on the oocyte level (Lallemand et al., 1998). The 
observed embryonic lethality of 54% in mutants could be narrowed to a period between 
ED 14.5 and ED 16.5 (data not shown). In order to ascertain the tissue responsible for the 
lethality,  the  Cx43+/floxG138R  female  mice  were  mated  with  alphaMyHC-Cre  or 
Nestin-Cre male mice to specifically activate the mutation in heart or early neurons. 
Figure  4.4: Genotype  statistics  for  progeny  from heterozygous  Cx43floxG138R  mice  after 
mating with PGK-, alphaMyHC- or Nestin-Cre mice (see next page).  
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The ubiquitous expression of the mutated gene after matings with PGK-Cre mice results in the 
reduction of the number of littermates from the expected 50% to 23% of mutants in a litter. The 
conditional activation of the Cx43G138R mutation in the heart (alpha-MyHC-Cre mating) led to 
a smaller reduction in the expected number of mutants per litter from the expected 25% to 14% 
born.  The activation of  the mutation in early neurons does not  influence the survival  of  the 
mutants (Nestin-Cre mating); (n =number of litters). (Scale bars = 1 mm)
Conditional activation of the Cx43G138R mutation in the heart (29 matings) revealed a 
reduction  in  the  expected  number  of  mutants  in  a  litter  (mutants  were 
Cx43+/flox:alphaMyHC-Cre;  expected  frequency  of  mutants:  25%,  born:  14%  and 
reduction: 44%). Thus, the lethality of mice with cardiac-specific mutation was similar to 
that observed with the ubiquitous mutants (44% to 54%; P = 0.1, n.s.) and occurred at the 
same embryonic  stage.  In  contrast,  the  activation  of  the  point-mutated  gene  in  early 
neurons, using the Nestin-Cre mice (n = 15 matings), did not influence the survival of the 
heterozygous mutants (mutants were Cx43+/flox:Nestin-Cre). 
The surviving cardiac-specific mutants died during the first 6.5 months after birth (Fig. 
4.5). Thus, these data imply that the mutant mice die because of cardiac alterations.
Figure  4.5:  Premature  death  in 
adult  cardiac-specific mutants.  The 
Kaplan–Meier  survival  curve  of 
Cx43+/floxG138R:  alphaMyHC-
Cre mice (n  =16) in comparison to 
wild-type  mice  (n  =20)  shows 
premature death of cardiac-specific 
mutants between 2 and 6.5 months 
after birth.
These findings reveal the heart as the responsible tissue for the observed lethality and 
demand further examinations. 
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4.1.4 Morphologic development  of the heart and connexin expression in ODDD  
mutated hearts 
As Cx43-deficient mice died at birth due to a failure in pulmonary gas exchange as a 
result of an altered right ventricular outflow tract (Reaume et al., 1995), it was important 
to check the heart morphology in adult mutants (Fig. 4.6 A-D). Nine Cx43+/floxG138R: 
alphaMyHC-Cre hearts, two Cx43+/+:alphaMyHC-Cre hearts and three Cx43+/+ hearts 
were morphologically investigated. Two of the nine Cx43+/floxG138R:alphaMyHC-Cre 
hearts were smaller than that of the control groups. Microscopically, no structural defects 
were  detected.  Both  atrial  septation  and  ventricular  septation  were  normal.  The 
pulmonary  outlet  was  open,  in  contrast  to  subpulmonary  obstruction  with  abnormal 
pouch formation  in  Cx43-deficient  mice.  Coronary arteries  originated  from the  aorta 
normally, and their arrangement appeared the same as in wild-type mice.
Figure  4.6: Conditional  expression  of  Cx43G138R  in  the  heart  reveals  normal  cardiac 
morphology. Morphological analyses reveal no obvious change in the right ventricular outflow 
tract or the septation of mutant hearts (C and D) in comparison to wild type controls (A and B). 
(E-H) Immunofluorescence analyses indicate localization of Cx43 in controls (E and F) and in 
heterozygous Cx43G138R mice (G and H), suggesting an unhindered trafficking of the mutated 
proteins in vivo. Some dyslocalization of Cx43 protein from intercalated discs to lateral contact 
membranes is apparent [phase contrast and Cx43 staining merged in (E) and (G); Cx43 staining 
in (F) and (H); scale bar = 20 µm].
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Immunofluorescence analyses of connexin isoforms in the ventricle revealed a slightly 
altered  localization  of  these  proteins  in  mutated  hearts.  Cx43-specific  signals  were 
detected  in  intercalated  discs  and  in  lateral  contact  membranes  of  ventricular 
cardiomyocytes  (Fig.  4.6G–H),  indicating  an  unhindered  trafficking  but  a  slightly 
changed localization of the Cx43G138R channels. Additional analyses to determine the 
expression of Cx40 in the atria and Cx45 in the ventricle, where Cx43 and Cx43G138R 
are co-expressed, revealed no changes in mutated relative to wild-type hearts (Fig. 4.7). 
This suggests no trans-dominant effects of the mutated protein onto Cx40 and Cx45 in 
the heart.  Thus,  this  Cx43 mutation is  solely responsible for the effects  onto cardiac 
physiology described in chapter 4.1.5.
Figure 4.7:  Expression of  connexin proteins  in  the  ODDD mutated heart.  For  estimation of 
Cx40,  Cx43  and  Cx45  expression  in  mutated  hearts  immunoblot  analyses  were  performed. 
Besides  reduced  Cx43  levels  in  heterozygous  heart  specific  mutants  (Cx43+/floxG138R: 
alphaMyHC-Cre) and Cx43LacZ/G138R (see chapter 4.2 for detailed analysis) no alterations of 
Cx40 or Cx45 expression could be detected. 
The  Cx43  immunoblots  suggest  a  partial  non-phosphorylation  of  these  proteins  in 
mutants. This aspect has been investigated in detail and described in chapter 4.3.6.
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4.1.5 Cardiac function in heart specific Cx43G138R mutants (Cx43+/floxG138R: 
alphaMyHC-Cre)
In two ODDD families, severe cardiac abnormalities have been described resulting in 
sudden  cardiac  death  probably  due  to  arrhythmia  (Paznekas  et  al.,  2003).  All 
Cx43+/floxG138R:alphaMyHC-Cre mice died during the first 6.5 months postnatally (n 
= 16, Fig. 4.5). Thus, analyses of cardiac function followed to ascertain the impact of the 
Cx43G138R mutation in the heart and the cause of death in the heart specific mutants.
4.1.5.1 No alteration in echocardiography
Anesthetized mice were also functionally analyzed using echocardiography. This analysis 
yielded no significant changes to wild-type mice in regard to the heart frequency, left 
ventricular muscle mass, left ventricular end-diastolic volume or left ventricular ejection 
fraction (Fig. 4.8).
Figure 4.8:  Echocardiographic results yield no significant changes in mutant hearts. The mice 
were analyzed for heart frequency (A), left ventricular muscle mass (LVM) (B), left ventricular 
enddiastolic  volume  (LVEDV)  (C),  and  left  ventricular  ejection  fraction  (EF)  (D)  but  no 
significant changes compared to wild type could be observed in the investigated mutants. 
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4.1.5.2 Disturbed impulse propagation in surface electrocardiograms
The surface and intercardiac ECG studies showed significant changes in P, PQ, QRS and 
QTc intervals and R and RS amplitudes. The most prominent change was the broadening 
of  the  QRS  complex  and  decrease  in  the  R  wave,  indicating  disturbed  impulse 
propagation in the ventricle accompanied by low voltage ECG (Fig. 4.9 and Table 4.1).
Figure 4.9: Disturbed impulse propagation in mutated hearts. In comparison to wild-type hearts 
(A) the mutated ones clearly show a disturbed impulse propagation in the ventricle as seen in the 
striking broadening of the QRS complex in the surface ECG of the mutated hearts (B).
Cx43 
+/+
Cx43 
+/G138R
P
P (ms) 14.8±1.3 23.0±3.4 0.013
PQ (ms) 42.8±6.3 53.0±2.0 0.043
QRS (ms) 14.0±0.8 23.8±4.4 0.02
Qtc (ms) 30.1±1.6 36.7±3.4 0.023
R (mV) 0.55±0.07 0.12±0.02 0.001
RS (mV) 1.17±0.25 0.28±0.06 0.005
Table 4.1: Results of surface ECG analyses, including low voltage ECG in Cx43G138R mice. R, 
R-wave amplitude measured from the isoelectrical line to the maximum of R-wave; RS, maximal 
amplitude from the maximum of the R-wave to the most negative spike of the S-wave.
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4.1.5.3 Spontaneous arrhythmias ex vivo in Langendorff analyses
The functional cardiac ex vivo analyses in the Langendorff setup revealed spontaneous 
and  sustained  ventricular  tachycardias  or  other  types  of  cardiac  arrhythmias  starting 
directly after excorporation and continuing during perfusion in all mutants investigated 
(n=8), but in none of the wild-type animals (n=6; Fisher’s test: P=0.0003) (Fig. 4.10B–I). 
This  prevented  analysis  of  sinus  rhythm and  application  of  stimulation  protocols  to 
Cx43+/floxG138R:alphaMyHC-Cre  hearts.  Therefore,  no  systematic  evaluation  of 
conductive properties  could be carried out,  and the mechanism(s) responsible for the 
induction of these arrhythmias could not be further explored. Epicardial activation maps 
revealed a heterogeneous distribution of activity in the ventricles during these episodes.
Figure 4.10: Spontaneous cardiac arrhythmias developed in mutated hearts (see next page).
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(A)  Normal  impulse  propagation  and  activation  pattern  in  wild-type  (n  =  6)  but  ventricular 
tachycardias (VT) of all mutated (n  =  8) hearts in Langendorff measurements. The cumulative 
Langendorff  recordings  of  128 epicardial  electrograms clearly show repetitively directed and 
homologous conduction without signs of conduction disturbances or shifts of conduction speed 
and direction in wild-type hearts during sinus rhythm (A–D) but a chaotic appearance of field 
potentials  in  the  mutated  ventricles  during  a  polymorphic,  high-frequency VT (E–H).  Such 
polymorphic, incessant VTs were spontaneously present in all mutant hearts directly after the 
initiation of Langendorff  extracorporal  perfusion.  EAMs of the left  ventricular  epicardium at 
three different time points during sinus beats in wild-type or polymorphic VTs in mutant hearts 
are  shown  in  (B-D)  or  (F-H),  respectively.  The  false  color-coded  reconstruction  with  red 
representing  earliest  and  blue  representing  latest  epicardial  activation  shows  a  heterogenic 
distribution of field potentials with inconsistent direction and speed of ventricular conduction in 
the Cx43G138R mutated mouse heart (arrows) during VT. This indicates different conduction 
pathways during different VT beats as typically present in polymorphic VT.
4.1.5.4 Application  of  inhalation  anesthetics  induces  ventricular  arrhythmias  in  
cardiac-specific ODDD mutants
Ubiquitous and cardiac-specific mutants showed in contrast  to wild-type mice a high 
lethality  during  isoflurane  or  sevoflurane  anesthesia  following  standard  protocols.  In 
order  to  investigate  the  reason  for  the  obvious  incompatibility  towards  inhalation 
anesthetics,  ketamine  (10  mg/kg  weight)  with  disoprivan  (0.05  mg/kg  weight)  were 
administered  for  sedation  and  isoflurane  (0.3  % till  exitus)  was  increasingly applied 
during echocardiographic recording. Between 2 % and 5 % isoflurane, all investigated 
cardiac-specific  Cx43+/floxG138R:alphaMyHC-Cre  mutant  mice  developed 
tachycardias  and  ventricular  fibrillation,  whereas  wild-type  mice  tolerated  these 
concentrations.  Moreover,  mutated  mice  developed  apnea  at  normal  sinus-rhythm 
electrocardiograms,  indicating  possible  hemodynamical  complications  because  of 
electromechanical  uncoupling.  This  suggests  severe  electrical  and  electromechanical 
disturbances as the cause of death. 
However, ECGs could be successfully recorded with several mice before these alterations 
occurred. These data are already presented in Figure 4.8.
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4.1.5.5 Spontaneous arrhythmias in vivo
Using surface ECG recordings  in vivo under normal normoxic conditions, spontaneous 
arrhythmic  events  such  as  ventricular  extra  systoles  (VES)  were  observed  in  the 
Cx43+/floxG138R:alphaMyHC-Cre  mice  (Fig.  4.11).  The  frequency  and  severity  of 
arrhythmic  events  were  strongly  increased  by  hypoxic  stimulation  (Fig.  4.11  and 
Fig.4.12). In fact, VES developed with 5.1-fold higher probability during application of 
hypoxia in mutants, whereas no VES could be seen in wild-type littermates. Even VTs 
(defined as four or more consecutive VES events) could rarely be observed in mutated 
mice  (Fig.  4.11,  middle  panel);  none  of  the  tested  mice  died  during  the  hypoxic 
stimulations.
Figure 4.11: Cardiac arrhythmias recorded in vivo in cardiac-specific mutants. The frequency of 
the arrhythmias could be increased by hypoxia (hypoxia bars). Adjustment of O2 to normoxia 
largely abolished the arrhythmias. Arrhythmic events (VES) are displayed as individual points 
(VES during normoxia and under hypoxia).  Even VT (1 VT = 4 consecutive VES) could be 
recorded as a rare arrhythmic event during hypoxia (middle panel).
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Figure 4.12:
The occurrence of arrhythmic events 
(ventricular extrasystoles = VESs) increases 
only in cardiac specific mutants during 
hypoxic phases. Under normoxic conditions 
mutant mice developed VES (1.4 event per 
minute) whose frequency increased while 
applying 5-10 % O2 to 7.2 events per minute 
(P < 0.005, n = 4).
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4.2. Analysis of Cx43G138R/LacZ hemizygously mutated mice
Lethal homozygous connexin mutants which were viable in the hemizygous state were 
described  for  Cx43K258stop  (Maas  et  al.,  2004)  and  Cx31F137L (Schnichels  et  al., 
2007) expressing mice.  Also in case of the Cx43G138R mice this question remained 
open. The Cx43G138R hemizygous mutants (Cx43LacZ/G138R) which arose from the 
matings of Cx43LacZ (Theis et al., 2001) with Cx43G138R mice, were viable. These 
hemizygous ODDD mutants will be described in the following chapters.
4.2.1 Expression of reporter genes in the two Cx43 mutant mice
The Cx43LacZ/G138R mutants express two reporter genes driven by the Cx43 promoter. 
It was important to know whether the eGFP reporter protein indicating expression of the 
point-mutated  form  of  Cx43  is  co-localized  with  ß-galactosidase,  indicating  Cx43 
deficiency. This would demonstrate that the mutation is properly expressed in the mouse 
tissue.  As  already  mentioned,  both  reporter  genes  are  driven  by  the  same  (Cx43) 
promoter but the constructs used for the generation of the two mutants differ in their 
untranslated regions (UTRs). By insertion of the LacZ gene into the genomic locus of 
Cx43, the 3' regulatory region of the gene was modified but remained unaffected in the 
Cx43G138R mice. The co-immunfluorescence analyses using anti-eGFP, anti-LacZ and 
anti-GFAP antibodies revealed a very high co-localization of the two reporter proteins in 
astrocytes in the brain (Fig. 4.13) and in working cardiomyocytes in the heart (Fig. 4.14). 
Rarely only LacZ positive cells (5-8 cells in one field of sight) could be detected in the 
brain. 
These data confirm the proper localization of the G138R mutated form of Cx43 in the 
two tissues (the brain and the heart) and show a negligible percentage (<1%) of not co-
localized signals. Cells only expressing LacZ but not GFP might posttranscriptionally 
down-regulate expression of Cx43. Such regulation of this connexin by microRNA was 
reported during skeletal muscle development for MIR-2006 (Kim et al., 2006) and the 
cardiac arrhythmogenesis for miR-1 (Yang et al., 2007). The function of this very small 
cell population in the brain remains unclear.
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Figure 4.13: Expression of the reporter genes eGFP and LacZ in hemizygous Cx43G138R/LacZ 
hypocampi. (A+B) Both reporter genes are driven by the Cx43 promoter and are expressed in the 
hemizygously mutated ODDD mice at  the same time in  the  astrocytes  (C).  (D)  The merged 
picture shows a high coexpression of the two genes, whereas no GFP or LacZ staining could be 
detected in wild-type GFAP positive cells (E-H). (Scale bars = 100µm)
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Figure 4.14:  Expression of GFP, LacZ and Cx43 in ventricular  cardiomyocytes.  (A) Cardio-
myocytes of Cx43LacZ/G138R express cytosolic GFP and ß-galactosidase in the nuclei, (C) no 
expression of the reporter genes in wild-type animals. (B) Cx43 containing gap junction plaques 
are visibly smaller than those found in control mice (D). (Scale bars=20µm in A and C, scale bars 
= 100µm in B and D)
Furthermore the localization and expression of Cx43 of the hemizygously mutated mice 
especially in the heart was analyzed (Fig 4.14B). In comparison to wild-type controls 
(Fig 4.14D) the size of Cx43 immunosignals which may represent gap junction plaques 
was apparently diminished but still localized in the intercalated discs.
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4.2.2 Cx43G138R hemizygousity is not compensated by Cx30 over-expression in 
the brain
Both, Cx43 and Cx30 are expressed by astrocytes in the mature central nervous system 
(Nagy et  al.,  1999).  Astrocytes  play a  neurosupportive role  in  the brain by secreting 
cytokines  and  neurotrophic  factors.  However,  the  function  of  astrocytic  connexins 
remains  largely unknown.  The gap  junction  channels,  especially  consisting  of  Cx43, 
seem to play an important role in the brain by decelerating of spreading depression or 
locomotory activity (Theis et al., 2003). The same authors report a partial compensation 
of the astrocytic Cx43 deletion by Cx30 up-regulation. The coordinated expression of 
both  connexins  was  also  seen  in  Cx43flox/flox:Nestin-Cre  mice,  the  only  living 
homozygous  ODDD  mutant.  Here,  an  2.5  fold  up-regulation  of  Cx30  was  detected 
relative to wild-type mice or other mutants (Fig. 4.15). 
Figure 4.15: Quantified expression of Cx43 and Cx30 in Cx43G138R mice (see next page). 
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The anti-Cx43 immunoblot (upper left) shows a normal phosphorylation of Cx43 in wild-type 
heart and brain but an obvious phosphorylation deficit of these proteins in all mice expressing the 
Cx43G138R mutation. Quantitative evaluation (upper right) revealed a strong down-regulation of 
Cx43 expression in  Cx43del/G138R mice to  approx.  15% and in  Cx43+/flox:Nestin-Cre and 
Cx43flox/flox:Nestin to 40%. Quantification of anti-Cx30 immunoblots (bottom left and right) 
showed  no  significant  up-regulation  of  Cx30  expression  in  Cx43del/G138R  or 
Cx43+/flox:Nestin-Cre mice but hints to a possible compensation by Cx30 in the homozygous 
brain specific mutants (Cx43flox/flox:Nestin-Cre). (n=3, respectively)
The hemizygous mice showed a strongly diminished expression of Cx43 to approx. 15% 
and no alteration of Cx30 expression. Thus, the hemizygous ODDD mice with strongly 
reduced Cx43 expression and lack of Cx30 compensation are an interesting model to 
explore connexin function in the brain. 
4.2.3 Nearly all Cx43G138R hemizygous mutants develop similar morphological  
abnormalities characteristic as ODDD patients
The most noticeable feature of the hemizygously mutated mice was the clear increase of 
penetrance of the ODDD specific phenotypes. Thus, the appearance of syndactylies in 
these  mice  shifted  from  70%  in  heterozygous  mutants  to  95%,  whereas  enamel 
hypoplasia  and  craniofacial  alterations  could  be  observed  in  over  90%  of  all  born 
Cx43Lacz/G138R mutants. The high penetrance in these mice was utilized to analyze the 
underlying molecular mechanisms for the morphologic anomalies in ODDD mutants and 
were used in all following analyses of this chapter.
4.2.4 Syndactylies are caused by decreased apoptosis in ODDD mutated mice
The programmed cell  death occurs in the development of the limb for separating the 
digits by removing the tissue in between. 
To test for apoptosis in the mutated limbs embryonic paws at ED12.5 were prepared from 
Cx43LacZ/G138R mutated and control mice, sectioned and used for TUNEL assays (Fig. 
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4.16C and D). Apoptotic cells were admittedly present in mutant limbs but located far in 
the interdigital  tissue (arrows in Fig 4.16D) in comparison to controls (arrow in  Fig 
4.16C).  The limitation  of  apoptosis  in  embryonic  limbs could  be correlated  with the 
appearance of syndactylies in the adult (Fig. 4.16B). Here, the adhesion of the digits was 
prominent, the separation occurred initially but was strongly limited. Hence, syndactylies 
in ODDD mutated mice are likely caused by impaired apoptosis of the interdigital tissue.
Figure 4.16: Syndactylies are caused by disturbed apoptosis in ODDD mutated mouse limbs. (A 
and B) GFP fluorescence could be detected in hemizygously mutated mice paws (B) indicating 
the  expression  of  the  Cx43G138R mutation,  whereas  wild-type  paws  (A)  showed  no  GFP-
fluorescence.  (C)  Normal  apoptosis  in  wild-type  embryonic  limbs  (ED12.5)  and  disturbed 
apoptosis  in  mutants  (D).  Arrows  point  at  the  apoptotic  progression  clearly  showing  the 
impairment of apoptosis in mutants (D). (Scale bars in A and B = 5 mm, in C and D = 500 µm)
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4.2.5 Expression of diverse morphogens in Cx43 mutated mice
The  morphologic  phenotypes  of  the  Cx43G138R  expressing  mice  like  syndactylies, 
craniofacial or dental anomalies as well as osteopenia are developmental  disorders or 
disturbances  in bone homeostasis.  Important  for these processes  are  morphogens,  i.e. 
proteins  acting  mainly  during  differentiation  and  patterning.  Thus,  the  expression  of 
some  of  these  proteins  in  mutated  and  control  animals  was  analyzed  and  will  be 
presented in this chapter. 
4.2.5.1 Detection of morphogens in mutated and control whole mount embryos
The expression and localization of crucial developmental markers like bone morphogenic 
protein 2 (Bmp2),  sonic  hedgehog (Shh) and Noggin were analyzed in  whole mount 
embryos using appropriate antibodies. 
The  expression  of  the  key  protein  (Bmp2)  regulating  osteoblast  differentiation  and 
induction  of  apoptosis  between  the  digits  was  strongly  diminished  in  mutants  in 
comparison to wild-type controls (Fig. 4.17A and B). Most prominent was the reduction 
in the craniofacial region ( Fig. 4.17C and E) as well as in fused neural tube (arrows in 
Fig 4.17D and F) in mutant embryos. The expression of the processed N-terminal peptide 
of Shh was also altered. The diffuse localization of Shh in the zone of polarizing activity 
in limb buds expanded more in control animals (Fig 4.17G and H) than in the ODDD 
mutated  ones  (Fig  4.17I  and  J).  To  distinguish  whether  an  excessive  blockade  of 
apoptosis between the digits led to syndactylies in mutants, the expression of Noggin was 
analyzed.  Noggin  is  an  antagonist  of  apoptosis  preventing  the  tissues  from  death. 
However, no difference in the expression of this protein could be detected between the 
two genotypes. 
Thus,  it  can  be  excluded  that  a  partial  blockade  of  cell  death  between  the  digits  is 
responsible for the development of syndactylies in ODDD mutated mice. However, the 
induction of apoptosis by Bmp2 could be affected leading to the interdigital fusion. This 
suggests a reduction of Bmp2 expression in mutated embryos.
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Figure 4.17: Expression of morphogens in ODDD mice. (A-F) Expression of Bmp2 proteins is 
reduced  in  Cx43LacZ/G138R  mutant  embryos  (B)  in  comparison  to  wild-type  mice  (A) 
(ED11.5). Bmp2 could be detected in craniofacial region (C) and the fused neural tube (arrow in 
D) in control  mice but showed a clear reduction in mutants (E or F).  Sonic hedgehog (Shh) 
expression was also reduced in the zone of polarizing activity in mutated limb buds (I and J) 
compared to wild-type ones (G and H) (ED11.5). The Bmp2 antagonist Noggin showed no clear 
alterations in its expression (K and L) between the genotypes (ED13.5). (Scale bars = 1 mm)
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4.2.5.2 Limb bud cultures express morphogens in vitro
Establishment of limb bud cultures can facilitate the examination of the Cx43 influence 
on  morphogen  expression.  Such  cultures  avoid  the  laborious  mice  matings  and 
preparations of embryos and allow analyses, like visualization of intercellular calcium 
concentrations, which are not possible in multilayered, three-dimensional tissues. 
Here, limb bud cultures were assessed and analyzed for their expression of Cx43, Shh 
and  Bmp2.  Furthermore,  their  molecular  characteristics  were  ascertained  using  anti-
vimentin and anti-Oct3/4 antibodies. 
In all cultures cells were found showing highly fluorescent signals after labeling with 
antibodies to the N-terminal peptide of Shh (Fig. 4.18A-C). Thereby fluorescent signals 
were also detected on adjacent regions of the Shh expressing cells which may indicate 
the secretion of the Shh peptide. A slight reduction of Shh positive signals was apparent 
in Cx43LacZ/G138R as well as Cx43LacZ/LacZ cultures. The combination of Shh and 
Cx43 immunofluorescence analyses revealed that both the ODDD mutated and wild-type 
cultures  expressed  Cx43  protein,  the  Cx43LacZ/LacZ  were  negative  for  Cx43  as 
expected (Fig 4.18A-F). Shh expressing cells also expressed this connexin protein (Fig 
4.18A and B). 
The  Bmp2  expressing  cells  showed  mesenchymal  characteristics  by  expression  of 
vimentin  and,  in  a  small  percentage  (approx.  1%),  also  stem cell  characteristics  by 
expression  of  the  transcription  factor  Oct3/4  (red  nuclei  in  Fig.  4.18  G-L).  A clear 
difference between the genotypes regarding the expression of Bmp2, vimentin or Oct3/4 
could not be seen in these immunofluorescence analyses.
For  quantitative  evaluation  of  Cx43,  Bmp2  and  Shh  expression,  cell  lysates  were 
separated on SDS gels for immunoblot analyses (Fig. 4.19). As positive control, lysates 
of embryoid bodies (EBs) were used which were obtained after a differentiation of HM1 
cells for 7 days. The hemizygously mutated cultures showed a reduced expression of all 
detected proteins:  Cx43,  Bmp2 and Shh. A similar  reduction of the two morphogens 
could be seen in Cx43 deficient cells which did not show any Cx43 specific bands as 
expected. Hence, the reduction of morphogen expression correlates with the expression 
of  Cx43  and  reflects  the  results  from the  immunohistochemistral  analyses  of  whole 
mount embryos (Fig. 4.15). 
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Figure 4.18:  The mesenchymal cells in limb bud cultures express sonic hedgehog (Shh), bone 
morphogenic protein 2 (Bmp2) and Connexin43 (Cx43). (A-F) Shh expressing cells (punctated 
green  staining)  could  be  found  in  all  cultures  independent  on  the  genotype,  whereas  Cx43 
expression (in blue) was diminished in Cx43 LacZ/G138R (E) or missing in Cx43 LacZ/LacZ 
cells  (F).  (G-L)  Most  cultured  cells  had  a  mesenchymal  origin  (vimentin  expression,  green 
staining), some expressed the stem cell markers Oct3/4 (blue nuclei in G-I) and Bmp2 (punctated 
red staining in J-L). (Scale bars = 20 µm)
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Figure 4.19:  Expression of Connexin43 (Cx43), Sonic hedgehog (Shh) and bone morphogenic 
protein 2 (Bmp2) in limb bud cultures. The expression of Cx43 is reduced in Cx43G138R/LacZ 
and missing in Cx43Lacz/LacZ cells. These mutated cells also show a clear reduction of Shh and 
Bmp2 expression in comparison to wild-type Cx43 limb bud cells or embryoid bodies. Embryoid 
bodies (differentiated for 7 days from HM1 cells) were used as positive controls. 
4.2.5.3 Calcium imaging of limb bud cultures
In order to understand the correlation between Cx43 and morphogen expression, as seen 
in whole mount embryos and limb bud cultures, further cell culture experiments were 
done. Recently, the intracellular calcium concentration has been described to be elevated 
by Shh application to differentiating embryonic stem cells and suggested to be a cascade 
modulator (Heo et al., 2007). On the other hand, it is well known that the two second 
messengers  Ca2+ and  inositol-1,4,5-trisphosphate  (IP3)  are  able  to  pass  gap  junction 
channels  (Saez  et  al.,  1989).  Thus,  it  was  important  to  investigate  the  ability  of  the 
mutated gap junction channels to mediate the intercellular propagation of Ca2+ or IP3. 
Cx43G138R/LacZ, Cx43LacZ/LacZ and control limb bud cultures were loaded with the 
calcium  indicator  Fura-2AM  (Invitrogen,  Karlsruhe,  Germany)  and  were  tested  for 
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spreading of the spontaneous calcium oscillations to adjacent cells (Fig. 4.20). Here, cells 
expressing the point mutated form of Cx43 as well  as Cx43 deficient cells  (data not 
shown) were able to oscillate but failed to transfer Ca2+ or IP3 to neighboring cells (Fig. 
4.20A-D and E). Figure 4.20E shows three clear increases in calcium concentration of 
cell 1 without propagation into cells 2 or 3 whereas wild-type cells (Fig. 4.20F and G-J) 
showed a distribution of the raised calcium into cell 2. 
Figure 4.20: Visualization of calcium concentrations in limb bud cultures. Spontaneous calcium 
oscillations (in cell 1) which cannot be propagated to neighboring cells (cell 2 and 3) in mutated 
limb  bud  cultures  (A-D  time  scaled)  are  illustrated  in  a  diagram  (E).  Here,  the  particular 
oscillations could only be detected in  one single cell (E), whereas wild-type cells (cell 1) showed 
a spreading of calcium or IP3 to surrounding cells (cell 2) (G to J and evaluation in F). (Scale bars 
= 20µm)
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4.3  In vitro analyses of the Cx43G138R and other ODDD associated Cx43 
mutations
4.3.1 The Cx43G138R mutation leads to a loss of Cx43 mediated conduction in  
HeLa cells, mouse embryonic stem cells (HM1) and primary cardiomyocytes
In order to determine the function of the Cx43G138R mutated protein, microinjections of 
tracers  and  electrophysiological  studies  were  performed  using  mouse  embryonic 
cardiomyocytes, ES cells and stably transfected HeLa cells (Fig. 4.21A–H). The micro-
injections into cardiomyocytes resulted in a reduction of neurobiotin transfer by 94%, 
thus  indicating  that  only  6%  of  connexin-mediated  conduction  is  maintained  in 
Cx43+/G138R cardiomyocytes (Fig. 4.21I). 
Furthermore,  the  neurobiotin  transfer  in  Cx43+/G138R  mouse  ES  cells,  which 
heterozygously expressed the Cx43 mutation, was reduced by 79% (Fig. 4.21I). Because 
of possible co-expression of additional connexins in cardiomyocytes (Cx45) or ES cells 
(Cx45 and Cx31),  microinjection analyses using cells  expressing only Cx43 isoforms 
were performed. 
Thus, HeLa cells stably expressing Cx43G138R alone or in the presence of Cx43WT 
proteins were investigated. No neurobiotin transfer could be detected in cells expressing 
only Cx43G138R (n = 15), whereas in cells co-expressing Cx43WT and Cx43G138R, 
neurobiotin transfer was slightly higher, suggesting a strong reduction or even a loss of 
Cx43-mediated conductance in Cx43+/G138R mice. Electrophysiological studies using 
dual whole-cell  voltage clamp (Kreuzberg et  al.,  2005) revealed that all  14 examined 
HeLa  Cx43G138R cell  pairs  exhibiting  eGFP fluorescence  (Cx43G138R-IRES-eGFP 
construct) demonstrated complete absence of coupling. 
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Figure  4.21: Cx43-mediated  coupling  is  disturbed  in  cells  expressing  the  ODDD-mutated 
proteins. Intercellular transfer of microinjected neurobiotin in wild-type Cx43-expressing cells 
[primary mouse cardiomyocytes (A and C), ES cells (E) and HeLa cells (G)] in comparison to 
Cx43G138R-expressing cells [primary mouse cardiomyocytes (B and D), ES cells (F) and HeLa 
cells (H)]. In (C) and (D), the coupling area is outlined in pseudo-color. The diagrams shown in 
(I) compare neurobiotin transfer in wild-type and mutated cardiomyocytes and stem cells as well 
as  in  HeLa  cells  expressing  Cx43WT or  Cx43G138R alone  or  co-expressing  Cx43WT and 
Cx43G138R. A residual coupling in approximately 2.5 cardiomyocytes (6.4%) was observed. In 
stem  cells  dye  transfer  was  substantially  higher  (six  cells;  20.8%).  HeLa  cells  expressing 
Cx43G138R alone or in parallel with Cx43WT showed a very low level of dye transfer. (Scale 
bars = 20 µm)
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4.3.2 Cx43 mediated conduction can be maintained in heterozygous animals by  
Cx43WT homotypic and Cx43G138R/Cx43WT heterotypic channels
In  order  to  determine  whether  Cx43-mediated  coupling  in  Cx43+/G138R  mice  is 
maintained  through  Cx43G138R/Cx43WT  heterotypic  channels  besides  wild-type 
homotypic  channels,  cell–cell  coupling  in  co-cultures  of  HeLa  cells  expressing 
Cx43G138R and Cx43-eGFP (fusion construct) was examined. Well distinguishable and, 
in many cases, multiple junctional plaques were found in the contact regions between 
cells expressing Cx43G138R and cells expressing Cx43-eGFP (Fig. 4.22). Figure 4.22B 
shows  the  averaged  dependence  of  junctional  conductance  (Gj)  on  transjunctional 
voltage (Vj) that was obtained by measuring junctional current (Ij) dynamics over time in 
response to long (150 s) Vj ramps that change from 0 to +120 mV and from 0 to -120 mV 
[for more details see Fig. 3 in (Rackauskas et al., 2007)]. In all nine examined cell pairs, 
Gj2Vj dependence was asymmetric with higher Vj gating sensitivity at positive voltage 
on the Cx43-eGFP side. GJC gating at the single-channel level (Fig. 4.22C) shows a 
tendency to open during a negative voltage step and to close during a positive voltage 
step, applied to the HeLaCx43-eGFP cell. This gating asymmetry at the single-channel 
level is in accordance with macroscopic Gj2Vj dependence, as shown in Figure 4.22B. 
Figure 4.22D shows the Ij record of a single channel in a heterotypic junction during 
application of hyperpolarizing Vj step of 87 mV with a HeLaCx43G138R cell. In the 
example  shown,  the  single  channel  conductance  at  the  open  state  is  ~103  pS,  and 
channels mainly gate between the open state and a substrate or the residual state with a 
conductance of ~25 pS. This kind of gating is ascribed as the fast gating (Bukauskas et 
al., 2006). Besides the fact that most gating transitions are between open and residual 
states of ~78 pS in magnitude, more rarely transitions between the open state and the 
fully closed state could be observed (indicated by arrows), which can be ascribed to the 
slow gating (Bukauskas et al., 2004). Earlier, it was reported that Cx43-eGFP channels 
exhibit the slow but not the fast gating mechanism. Therefore, the data shown in Figure 
4.22D should be ascribed to the gating of Cx43G138R hemichannels, which presumably 
retain  both  fast  and slow gating  mechanisms  such as  wild-type  Cx43.  Gating  to  the 
substate can also be seen in Figure 4.22D at the negative Vj step. Both macroscopic and 
microscopic gating properties shown in Figure 4.22B and D suggest that Cx43G138R 
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hemichannels  exhibit  higher  Vj  gating sensitivity than  Cx43-eGFP hemichannels  and 
presumably gate at negativity on the cytoplasmic side of Cx43G138R. 
Figure  4.22: Cx43–eGFP/Cx43G138Rheterotypic  junctions,  shown  in  (A),  form  junctional 
plaques (see arrows) in the junctional region between HeLaCx43G138Rcell  (left/top) exhibiting 
homogenous eGFP in cytoplasm and HeLaCx43-eGFP cell  (right/bottom) exhibiting punctate 
staining of eGFP prominently in contacting membranes. (B) Summarized junctional conductance 
dependence on transjunctional voltage (Gj2Vj) measured in nine cell pairs forming heterotypic 
Cx43–eGFP/Cx43G138R  junctions.  These  exhibit  an  asymmetric  Vj  gating  with  higher 
sensitivity at positive voltages on the HeLaCx43-eGFP side. (C) Unitary opening and closing 
events at the single-channel level of Cx43–eGFP/Cx43G138R heterotypic GJ channels seen as 
stepwise  junctional  current  (Ij)  transitions  in  response  to  consecutive  negative  and  positive 
voltage steps applied to the HeLaCx43-eGFP cell. Channels show a tendency to open during a 
negative  voltage  step and  to  close  during  a  positive  voltage  step that  is  in  accordance  with 
macroscopic Gj2Vj dependence shown in (B). (D) Single-channel record demonstrating that both 
fast  and  slow  gating  mechanisms  operate  in  Cx43G138R/Cx43  heterotypic  GJC.  During 
application of hyperpolarizing  Vj step to HeLa Cx43G138R cell, the channel operates mainly 
between the open state with a conductance of 103 pS and the residual state with a conductance of 
25 pS. Arrows point to transitions between the open state and the fully closed state.
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HeLa cells are known to express intrinsically Cx45, but at a very low level (Rackauskas 
et al.,  2007). If one assumes that the cell–cell  coupling shown occurs through Cx43-
eGFP/Cx45 heterotypic junctions then:
(i) the  macroscopic  Gj/Vj  dependence  should  be  more  asymmetric  with  higher 
voltage sensitivity at positive Vj (Bukauskas et al., 2002),
(ii) single-channel conductance of the open state should be ~55 pS (Bukauskas et al., 
2002) instead of ~100 pS (Fig. 4.22D), 
(iii) among 14 examined HeLaCx43G138R cell pairs, at least one or few of them 
should  show  coupling  with  some  Cx45  channels  instead  of  full  absence  of 
coupling and 
(iv) junctional plaques should be much smaller than those shown in Figure 4.22A 
(Rackauskas  et  al.,  2007).  Therefore,  the observed coupling is  not  due to  the 
formation  of  Cx43/Cx45 instead  of  Cx43/Cx43G138R channels  but  it  can  be 
suggested that at Vj = 0 mV, only a fraction of Cx43G138R hemichannels are 
open. At Vj = 0 mV, open probability of the Cx43WT hemichannel is close to 1 
and therefore the open probability of Cx43G138R/Cx43WT GJ channels will be 
limited by the open probability of Cx43G138R hemichannels (pCx43G138R). If, 
for  example,  pCx43G138R  equals  0.1,  then  only  one  of  100  Cx43G138R 
homotypic  channels  will  be  open,  which  may  explain  the  low  functional 
efficiency of Cx43G138R homotypic junctions.
4.3.3 Cells expressing Cx43G138R show enhanced release of ATP
As recently described, some ODDD mutations can lead to the reduced release of ATP 
through  hemichannels  (Lai  et  al.,  2006).  To  investigate  whether  the  Cx43G138R 
mutation  alters  cellular  ATP release,  extracellular  ATP concentration  and  propidium 
iodide uptake of cultured cells expressing Cx43G138R were measured upon stimulation 
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in calcium-free solution or under hypoxic conditions (Fig. 4.23). 
All measurements revealed approximately doubled activity of ATP releasing channels in 
cells expressing the Cx43G138R mutation. The ODDD mutated channels expressed in 
HeLa cells released in calcium free medium 2.3 fold more ATP than Cx43WT expressing 
cells.  HeLa  transfectants  expressing  the  same  Cx43WT  background  but  different 
amounts of Cx43G138R (Cx43WT+Cx43G138R (++) or (+)) showed an ATP release in a 
Cx43G138R-dependent manner (Fig. 4.23A). The use of HeLa WT cells was important 
to  determine  the  background  ATP concentration  of  0.03  µM  which  was  not  due  to 
connexin expression. HeLa cells expressing Cx43 release twice as much ATP than the 
wild type cells indicating the presence of functional hemichannels (Fig. 4.23A). 
The heterozygously recombined ES cells expressing the ODDD-mutated Cx43 besides 
Cx43WT released 2.0-fold more ATP than wild-type ES cells cultured in calcium-free 
medium (Fig. 4.23B and C). Furthermore, they could be stimulated by chemical induced 
hypoxia for 6 or 12 minutes. Here, a gradual increase of ATP in the extracellular  medium 
could be detected (Fig. 4.23 C). 
Cardiomyocytes derived from embryonic Cx43+/floxG138R: alphaMyHC-Cre or wild-
type hearts on ED 12.5 or ED 16.5 were tested in the hypoxic incubator. The activity of 
ATP-releasing channels in oxygen-dependent cardiomyocytes on ED 16.5, but not in the 
oxygen-independent ED12.5 cells, could be stimulated by hypoxia (Fig. 4.23D). A 1.8-
fold higher ATP concentration in media from mutant cells was measured. The increased 
activity of ATP-releasing channels was also confirmed by propidium iodide uptake in 
embryonic cardiomyocytes stimulated in calcium-free medium (Fig. 4.23E). The mutated 
cells exhibited 2.5-fold higher ATP release than wild-type cells.
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Figure 4.23: Cx43G138R leads to increased activity of ATP-releasing channels. Measurements 
of  ATP concentrations in media of  cultured cells  expressing Cx43G138R (A - D), and tracer 
uptake studies (E) showed a doubled activity of ATP-releasing channels. (A) HeLa transfectants 
expressing different amounts of Cx43G138R protein reveal that the ATP release proportionally 
increases with the amount of Cx43G138R protein (+ = low expression, ++ = high expression). (B 
and C) Recombined, heterozygous ES cells expressing the mutation showed an increased activity 
of  the  ATP-releasing  channels  and  could  be  stimulated  by  zero  calcium  conditions  (B)  or 
chemical induced hypoxia for 6 or 12 min (C). (D) In oxygen-dependent cardiomyocytes (ED 
16.5), the activity of ATP-releasing channels could be observed after 1.5 h of stimulation in a 
hypoxic  incubator,  but  was  not  detected  in  oxygen-independent  cells  derived  from younger 
embryos  (ED  12.5).  (E)  Studies  of  tracer  uptake  of  Cx43+/floxG138R:alphaMyHC-Cre 
cardiomyocytes also indicate the doubled activity of these channels before and after stimulation.
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4.3.4 The activity of ATP releasing channels influences the beating frequency of  
embryonic Cx43 +/floxG138R:alphaMyHC-Cre cardiomyocytes
To investigate the potential functional relevance of ATP-releasing channels, the beating 
rates in mutant and wild-type cardiomyocytes were assessed. Embryonic cardiomyocytes 
isolated from cardiac-specific mutants exhibited a 1.6-fold higher beating frequency (242 
bpm) than wild-type cardiomyocytes (148 bpm; P=0.001) (Fig. 4.24). 
Figure 4.24:  Activity of  ATP-releasing channels influences the beating frequency of mutated 
cardiomyocytes.  Mutated  cardiomyocytes  beat  faster  than  the  wildtype  ones  (P=0.001). 
Application of FFA or the mimetic peptide Gap26 at concentrations blocking the ATP-releasing 
channel  activities  decreased  the  beating  frequency  of  mutant  cells  to  the  wild-type  level 
(P=0.001).
This finding in combination with the increased ATP release and dye uptake indicated an 
ATP  release  channel-dependent  positive  chronotropic  effect.  This  was  further 
investigated by using peptides and drugs that have been reported to inhibit the activity of 
ATP-releasing hemichannels. Flufenaminic acid (FFA) (50 mM) or the mimetic peptide 
Gap26 (300 mM) blocked the ATP-releasing channels, whereas the activity of GJCs was 
not  affected  (Fig.  4.25). Both  of  these  pharmacological  agents  reduced  the  beating 
frequency of mutated cardiomyocytes to the level of wild-type cardiomyocytes (FFA: 
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155  bpm  and  Gap26:  143  bpm),  supporting  a  functional  impact  of  ATP-releasing 
channels.
Figure 4.25: Determination of hemichannel blocking concentrations of FFA and Gap26. (A) Gap 
junction  channel  activity  was  not  changed  neither  by  50  µM  FFA nor  by  300  µM  Gap26. 
However, increasing concentrations of FFA (125 µM and 250 µM) gradually inhibited the spread 
of injected dye. (B) Chemical structure of FFA. (C) The predicted binding of Gap26 to the first 
extracellular loop of Cx43 and its aminoacid sequence. (D) Abolishment of hemichannel activity 
by 50 µM FFA and 300 µM Gap26 after 20 min incubation at 37°C.
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4.3.5 Determination of the half-life of mutated and wild-type Cx43 proteins in  
HeLa cells
A possible explanation for the observed increased ATP releasing channel activity of some 
Cx43 mutants (Cx43I31M, Cx43G138R, Cx43G143S) could be a disturbed turnover of 
the proteins resulting in an increased amount of channels in the membrane. Thus, pulse-
chase experiments followed by Cx43 immunoprecipitations with lysates from mutant and 
wild-type Cx43-expressing cells were performed (Fig. 4.26). 
Figure 4.26: Pulse-chase analyses indicate degradation defects in some ODDD mutants.  The 
G138R as well as G143S mutants showed a halflife increase from 2.7 h in Cx43WT (A) to 4.8 h 
in  G138R (C)  and 3.7 h  in  G143S (D) mutants,  suggesting  a  degradation  problem of  these 
proteins. The I31M (B) and H194P (E) mutated proteins showed no obvious turnover alterations, 
as indicated by the similar half-lives (2.8 and 2.2 h, respectively)
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The Cx43G138R and G143S mutations showed an increased half-time (t1/2,G138R = 4.8 h, 
t1/2,G143S = 3.7 h) (Fig. 4.26C and D). However, the I31M mutation, which also exhibited 
increased hemichannel activity, did not show an obvious turnover defect (t1/2,I31M = 2.8 h) 
(Fig.4.26B),  similar  to  the  H194P mutation  without  altered  hemichannel  activity,  the 
Cx43H194P mutation  (t1/2,H194P = 2.2  h).  The half-life  of  Cx43 wild-type  protein was 
confirmed to be 2.7 h.
4.3.6 The  phosphorylation  of  Cx43G138R  and  other  ODDD  associated  Cx43  
mutants is largely disturbed
Previously,  it  has  been  described  that  the  phosphorylation  of  Cx43  regulates  gap 
junctional and even the activity of ATP-releasing channels (Evans et al., 2006). Therefore 
it had to be tested whether the phosphorylation of Cx43G138R-containing channels is 
affected in  vitro and  in  vivo.  Immunoprecipitations  of  Cx43  from  32P-labeled  HeLa 
transfectants (Fig. 4.27A) and immunoblot analyses of heart lysates (Fig. 4.27B) clearly 
showed a partial lack of phosphorylation of the Cx43G138R isoform. 
Figure  4.27:  Cx43G138R is  not  phosphorylated  at  the  P2  state  in  vitro as  well  as  in  vivo. 
Immunoprecipitation of Cx43 from  32P-labeled HeLa cells and immunoblot analyses of tissue 
lysates  are  shown.  (A)  Equal  numbers  of  Cx43-expressing  cells  (culture  dish  tested  by  35S 
methionine labeling, left  picture) were labeled with  32P ATP (right picture).  Subsequent Cx43 
immunoprecipitation  reveals  a  reduced  phosphorylation  of  Cx43G138R protein  by 80%.  (B) 
Immunoblot analyses show lack of P2 phosphorylation of Cx43G138R protein in hearts. 
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Equal  amounts  of  Cx43WT-  or  Cx43G138R-expressing  cells  (see  35S  methionine 
labeling) were labeled with [gamma32P]ATP, followed by immunoprecipitation of Cx43. 
The  results  clearly  indicate  that  up  to  80%  of  the  Cx43G138R  protein  is  not 
phosphorylated,  in  comparison  with  Cx43WT.  Immunoblot  analyses  also  showed  in 
Cx43+/floxG138R:alphaMyHC-Cre hearts that the P2 phosphorylation isoform of Cx43 
is absent.
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5. Discussion
5.1 Generation of Cx43G138R expressing mice
The Cx43G138R expressing mice were generated by homologous recombination of the 
conditional  construct  shown in  Fig.  1.10  which  has  been  cloned during  my diploma 
thesis (2004). This construct allows the targeted exchange of the endogenous Cx43 wild-
type  coding  region  by  a  loxP  sites  flanked  wild-type  gene  followed  by  neomycin 
resistance  and  Cx43G138R-IRES-eGFP cassettes.  The  region  flanked  by  loxP  sites 
(Cx43  wild-type  and  neomycin  genes)  could  be  conditionally  removed  after  Cre 
mediated  recombination.  The  remaining  Cx43G138R-IRES-eGFP  cassettes  were 
expressed driven by the endogenous Cx43 promoter. The combination of these cassettes 
allows the labeling of cells expressing the G138R mutated protein, the only way to detect 
this expression since no antibodies were available to distinguish between wild-type and 
mutated Cx43 isoform. 
After  transfection  of  the  embryonic  stem  (ES)  cells  only  one  of  251  clones  had 
undergone correct homologous recombination which corresponds to a recombination rate 
of 0.4 %. The most PCR positive ES cell  clones showed a lack of 8484 bp band in 
Southern  blot  analyses  using  BamHI  and  Cx43-internal  probe  (data  not  shown  but 
resembles the difference between +/Cx43G138R and +/flox alleles in Fig. 4.1D). This 
implies the absence of the Cx43 wild-type gene and a partial integration of the construct 
into the locus. It is probable that the unusually big internal homology, i.e. two almost 
identical  genes  except  of  one basepair  in  Cx43G138R relative  to  Cx43 wild-type,  is 
responsible for the very rare homologous recombination. This assumption is supported 
by  observations  of  Robert  Requardt  during  his  PhD  thesis.  He  used  a  very  similar 
construct to that one used for the generation of the Cx43G138R expressing mice. Despite 
an extension of the homology regions he ascertained a similar low recombination rate of 
0.5%. 
The clone no.234 which had undergone correct homologous recombination was used for 
blastocyst  injection  and,  after  transduction  with  the  biologically  active  Cre  peptide 
(Nolden et  al.,  2006),  for other  in vitro analyses,  e.g.  microinjections of dyes to test 
channel function or ATP release assay to check hemichannel activities. 
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5.2 Cx43G138R  expressing  mice  represent  a  new  conditional  mouse  
model for ODDD
The G138R mutation is localized in the cytoplasmic loop of the membrane-embedded 
Cx43 protein, i.e. the receptor domain for the C-terminal tail in the ball-and-chain model 
describing the opening and closing of a gap junction channels  (GJC) (Delmar et  al., 
2004). This mutation was characterized in transfected cells as a dominant-negative one 
inhibiting the gap junctional function of wild-type Cx43 (Roscoe et al., 2005). Thus, this 
mutation leads to a lack of GJC activity, although the Cx43 protein is still expressed in 
the cell membrane. These properties clearly distinguish the Cx43G138R mutation from 
Cx43 null mutant mice that do not express the Cx43 protein and both, the Cx43G60S and 
Cx43I130T mutations, where the mutated protein is largely excluded from the plasma 
membrane (Flenniken et al., 2005; Kalcheva et al., 2007). This PhD work confirms the 
dominance of the G138R mutation using embryonic cardiomyocytes from heterozygous 
mice and showed a strong (approx. 94%) reduction in cell-to-cell permeability of tracer 
molecules. 
Because  of  high  embryonic  lethality  of  the  ubiquitously  expressed  mutant  and  the 
necessity to compare mice of the same gender and age for bone morphological studies, 
only male mice were tested. Here, significant osteopenia with reduced bone volume and 
increased trabecular spacing was observed. This is most likely due to a decreased number 
of osteoblasts in the ODDD mutant mice, although the difference in osteoblast number 
was not  statistically significant.  Notably,  expression of Cx43G138R, as well  as other 
ODDD mutants in osteoblast-enriched calvaria cells, does not seem to alter the ability of 
these cells to differentiate and produce mineralized matrix in vitro  (McLachlan et al., 
2005).  Therefore,  the  dominant-negative  effect  of  the  mutant  proteins  may  not  be 
sufficient to completely inhibit wild-type Cx43 in committed osteoblasts, but it may be 
sufficient  to  interfere  with  earlier  commitment  of  stromal  cell  precursors.  A reduced 
number of osteoblasts in the ODDD transgenic mice would be consistent with this notion 
and would require precise examination of osteoblast's differentiation process. Analyses 
concerning  the  expression  of  crucial  developmental  proteins  will  be  discussed  in 
subsequent chapters (5.6 and 5.7). 
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5.3 Spontaneous  ventricular  arrhythmias  in  Langendorff  and  in  vivo  
recordings of mutated adult hearts
The cardiac function in adult  mice was determined by surface and intracardiac ECG, 
Langendorff and in vivo ECG measurements. 
5.3.1 Ventricular  arrhythmias  in  ODDD mutated  mice  are  mainly  due  to  the  
strongly decreased gap junctional coupling
Suppressed impulse propagation in the ventricle recognized by the broadening of the 
QRS complex and the lowering of its amplitude are similar to the situation in the Cx43-
deficient heart (Eckardt et al., 2006). The Cx43-mediated coupling in the heterozygous 
mouse  mutant  described  in  this  article  is  maintained  by  Cx43G138R-Cx43WT 
heterotypic  (103  pS  in  open  state)  and  Cx43WT-Cx43WT  homotypic  channels. 
Furthermore,  the  impulse  propagation  in  working  myocardium of  the  heterozygously 
mutated hearts can be maintained by heterotypic Cx45-Cx43  channels (55 pS) (Tab. 5.1) 
in  working  myocardium.  In  atria,  the  co-expressed  Cx40  cannot  generate  functional 
heterotypic  channels  with  Cx43,  i.e.  Cx40  mediated  coupling  is  not  affected  by the 
Cx43G138R  mutation.  The  impulse  propagation  via  the  recently  described  Cx30.2 
(Kreuzberg et al., 2006), is not changed in Cx43G138R mutated hearts. That is because 
Cx30.2 is not co-expressed with Cx43.
Cx30.2 Cx40 Cx43 Cx45
Cx30.2 9 18 18 17
Cx40 18 180 Not functional 45-50
Cx43 18 Not functional 115 55
Cx45 17 45-50 55 32
Table 5.1: Single  channel  conductances  in  pS of  cardiac  gap junction  channels  (homo-  and 
heterotypic  configurations).  Except  Cx40  and  Cx43,  all  cardiac  connexin  can  generate 
heterotypic channels with a different single channel conductance (Kreuzberg et al., 2006). 
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Thus, Cx43 mediated coupling can be maintained by Cx43G138R-Cx43WT heterotypic 
channels. However, the probability to generate these channels is low. 
The most striking findings in the Cx43G138R transgenic mice were the development of 
severe  ventricular  tachycardias,  the  missing  influence  of  the  mutation  on  heart 
morphology,  as  seen  in  the  Cx43-deficient  mice,  and  the  increased  activity  of  ATP-
releasing channels. 
In fact, the predisposition to arrhythmia in Cx43G138R mice can be explained by the 
uncoupling  of  ventricular  cardiomyocytes,  resulting  in  the  loss  of  directed  electrical 
conduction. This has been discussed for adult Cx43-deficient hearts (Eckardt et al., 2006; 
van Rijen et al., 2004), exhibiting ventricular arrhythmias that occur less frequently than 
in Cx43+/floxG138R: alphaMyHC-Cre mice. In this context, van Rijen et al. (van Rijen 
et  al.,  2004)  showed  that  only  a  low  percentage  of  cardiac  Cx43-depleted  animals 
developed  spontaneous  arrhythmias,  whereas  all  of  the  Cx43G138R  mice  exhibited 
spontaneous  VTs  implicating  an  enhanced  arrhythmogeneity  of  the  G138R  mutation 
versus the Cx43-deficient heart. The previously published Cx43 mutants by Flenniken et 
al. (2005) and Kalcheva (2007) showed no relevant QRS-prolongation, low-voltage ECG 
or spontaneous long-lasting ventricular arrhythmias, but significantly prolonged P-waves 
and AV nodal conduction blocks. Analogous conduction defects of the atria and AV node, 
i.e.  prolongation  and  first-degree  AV  nodal  block,  occurred  in  Cx43+/floxG138R: 
alphaMyHC-Cre mice. 
In  vitro analyses  revealed  a  strong reduction  of  Cx43 mediated  coupling  in  primary 
mouse cardiomyocytes, ES cells and HeLa cells (Fig. 4.21). The residual coupling was 
highest in cultured ES cells which can be explained by the expression of Cx31 and Cx45. 
Also in ventricular cardiomyocytes Cx45 is expressed besides Cx43. These cells showed 
a  94% reduction of tracer transfer in comparison to wild-type cells. In order to determine 
the Cx43 coupling in G138R mutants, connexin deficient HeLa cells were transfected 
with CX43WT and the mutated isoform. Neither Cx43G138R cells,  nor Cx43G138R-
Cx43WT transfectants showed very low transfer of the injected dye. These data prove the 
dominant behavior of the Cx43G138R mutation and suggest that the observed residual 
coupling in ES cell or primary cardiomyocytes are due to the co-expressed connexins.
Compared to other mouse strains  with alterations of Cx43 expression and function, the 
Cx43G138R mutant seems to have the strongest impact on cardiac arrhythmogeneity, 
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resulting  in  prominent  alterations  of  the  electrical  conduction  in  atria,  AV node  and 
ventricular  myocardium accompanied by severely enhanced arrhythmogeneity in  vivo 
and in the isolated heart. 
These findings point toward more severe alterations of intercellular coupling, conduction 
properties  and  other  Cx43  functions  when  compared  with  all  other  Cx43  mutants 
described to date. 
5.3.2 Ventricular arrhythmias in Cx43G138R mice can be aggravated by increased 
activity of ATP releasing channels which can be stimulated by hypoxia
A possible molecular basis for the striking arrhythmogeneity of G138R mutated hearts 
may be an enhanced activity of the ATP-releasing channels, which form a leak across the 
plasma membrane.  This could lead to a reduction in  the resting potential,  as  already 
proposed  for  mCx30.2  (Bukauskas  et  al.,  2006).  This  may  contribute  to  enhanced 
automaticity  and  initiation  of  extra-systolic  activity.  This  notion  is  supported  by 
aggravation  of  cardiac  arrhythmia  during  short  hypoxic  phases  (Fig.  4.11  and  4.12). 
Here, the opening times of ATP-releasing channels may be extended (Fig. 4.23C and D), 
leading to increased uncoupling of cardiomyocytes and thus to ventricular arrhythmia. 
The increased activity of ATP-releasing channels was observed in transgenic ES cells and 
embryonic  cardiomyocytes  expressing  the  same  amount  of  both  Cx43WT  and 
Cx43G138R  proteins.  Under  hypoxic  conditions  an  80%  increased  ATP  release  in 
oxygen-dependent  cardiomyocytes  (ED  16.5)  could  be  found,  but  not  in  oxygen-
independent ones (ED 12.5) (Fig. 4.23D). The physiological relevance of this gain-of-
function mutation regarding the ATP-releasing channel activity was studied in cultured 
cardiomyocytes. Here, the increased beating frequency of mutated cells could be lowered 
to  the  wildtype  level  using  Gap26,  a  mimetic  peptide  with  an  amino  acid  sequence 
corresponding to the region of the first extracellular loop of Cx43, as a blocker of ATP-
releasing channels. Furthermore, this experiment clearly shows that the blockade of ATP-
releasing channels in wild-type cells does not influence the beating frequency of wild-
type ventricular cardiomyocytes.  It  can be hypothesized that the increased activity of 
ATP-releasing channels and the associated increased release of ions could depolarize the 
membrane potential of the mutated cells. Under this aspect, the ATP-releasing channels 
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in  Cx43G138R  mutated  cells  show  some  analogy to  the  mutated  cardiac  potassium 
channel KCNQ1 (Chen et al., 2003). This gain-of-function mutation in the KCNQ1 gene, 
associated  with  the  long-QT syndrome  in  a  Chinese  family,  was  shown  to  be  the 
molecular  basis  for  the  autosomal-dominant  atrial  fibrillation  of  the  corresponding 
patients. However, this hypothesis needs to be corroborated by further experiments. The 
results suggest that increased activity of ATP-releasing channels in patients with ODDD 
mutations can aggravate the predisposition to arrhythmias, which is due to the strong 
reduction of gap junctional communication (van Rijen et al. 2004).
5.4 The mortality of ODDD mutated mice is due to the proarrhythmic  
action of the mutated Cx43 protein
The conditional approach allowed to investigate the influence of the G138R mutation in 
each cell type, where the Cre-recombinase can be specifically activated. Thus, the heart 
could be determined as the causative tissue for the embryonic lethality observed in the 
mutant, further underlining the importance of Cx43 for normal heart function. In humans, 
only  few  ODDD  patients  have  been  reported  to  suffer  from  a  cardiac  phenotype. 
However, the Cx43G60S, Cx43I130T and, even to a stronger degree, the Cx43G138R 
mutant  mice  exhibit  cardiac  dysfunctions,  which  have  not  been  reported  for  ODDD 
patients. Currently, it cannot be excluded that the mouse heart is more sensitive to Cx43 
ODDD like mutations than the human heart. On the basis of this work as well as the 
study by Flenniken et al. (2005) and Kalcheva et al. (2007), it appears possible that some 
ODDD patients may exhibit a cardiac phenotype during hypoxic stress that has not been 
detected yet.  It is also possible that up-regulation of other connexins such as Cx45 in 
human heart failure (Yamada et al., 2003) can partially compensate for the loss of Cx43 
coupling.  However,  such an up-regulation of Cx45 in the Cx43G138R mouse mutant 
could  not  be  found  (Fig.  4.7).  Because  of  the  embryonic  lethality  due  to  cardiac 
expression of the Cx43G138R mutation, a detailed investigation of the cardiac phenotype 
and its molecular basis was carried out. To exclude the influence of any other organs such 
as the central nervous system, all cardiac analyses were performed with mice specifically 
expressing  the  Cx43G138R  mutation  in  cardiomyocytes  (Cx43+/floxG138R: 
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alphaMyHC-Cre). In addition to the heart-related embryonic lethality, premature lethality 
could be observed in adult mutants during 2–6.5 months after birth, as determined by the 
Kaplan–Meier  survival  curve (Fig.  4.5).  The observed  in  vivo arrhythmias (Fig.  4.11 
and),  which are particularly pronounced during hypoxic periods (Fig.  4.12), could be 
responsible or at least be associated with the high lethality of ODDD-mutated mice. 
In  summary,  this  data  imply the  pro-arrhythmic  action of  G138R mutated Cx43 and 
underlines  the  importance  of  Cx43  containing  gap  junction  channels  in  cardiac 
physiology as recently shown in engraftment experiments of Cx43 expressing cells into 
post-infarct mouse hearts (Roell et al., 2007). 
5.4.1 Disturbed gap junctional coupling is possibly caused by a partial  lack of  
phosphorylation of the Cx43G138R protein
The loss of the P2 phosphorylation band that was observed in the mutated mouse hearts 
under in vitro and in vivo conditions has been suggested to be associated with the loss of 
Cx43  channel  function  (Oh  et  al.,  1993;  Solan  et  al.,  2007).  A  new  potential 
phosphorylation site on the tyrosine 137 (Y137) localized in the amino acid sequence of 
Cx43 before the  G138R mutation was predicted during my diploma thesis  using the 
NetPhos 2.0 algorithm (Fig.4.7 in Dobrowolski, 2004, diploma thesis). In order to check 
the assumption that the G138R mutation could disturb the phosphorylation on Y137, a 
potentially  critical  site  for  generation  of  the  P2  band,  a  Cx43  Y137F  mutation  was 
generated and expressed in HeLa cells (data not shown). The amino acid exchange from 
tyrosine to the  not-phosphorylatable phenylalanine has only negligible effects on the 
secondary  structure  of  the  protein.  Indeed,  Cx43  Y137F  were  significantly  less 
phosphorylated  than  the  Cx43  wild-type  proteins  in  the  parallel  analyses  to  those 
described  in  chapter  4.3.6.  However,  the  P2  phosphorylation  band  could  still  be 
generated in HeLa cells expressing these proteins. These data suggest Y137 as a new 
phosphorylation site, the first one located in the cytoplasmic loop of Cx43. However, this 
amino acid residue is not the key site for the generation of the P2 band. Thus, the glycine 
residue  at  position  138  of  Cx43  seems  to  contribute  to  the  occurrence  of  the  P2 
phosphorylation state and the function of GJCs. A possible explanation for this could be 
the influence of glycine 138 on the structure of the cytoplasmic loop, which contains two 
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distinct alpha helical regions promoting the binding to the channel closing C-terminal tail 
(Duffy et al., 2002). Interestingly, two human mutations, G138R and G143S, are located 
at  the boundaries  of the two alpha helices  respectively,  and lead to  closure of  Cx43 
containing gap junction channels in HeLa cells. Glycine is known to act as an alpha helix 
blocker, arginine or serine do not influence this structure. An extension of the predicated 
alpha helices in the G138R or G143S mutated loops could increase the binding to the C-
terminus and promote channel closure. 
5.4.2 The increased activity of ATP releasing channels in Cx43G138R expressing 
cells can be correlated with the increased half-life of the protein
The expression of increased activity of ATP releasing channels by Cx43 mutants as seen 
in I31M, G138R and G143S cells (Dobrowolski et al., 2007) is similar to that found with 
other connexin isoforms, such as Cx32F235C (Lin Liang et al., 2005) and Cx26G45E 
(Stong  et  al.,  2006)  mutants,  resulting  in  ‘‘leaky’’  hemichannels  (also  called  ATP 
releasing channels because of their doubtful molecular identity). However, some ODDD 
associated Cx43 mutations (Y17S, G21R, A40V, F52dup, L90V and I130T; Lai et al., 
2006) show a functional loss of these channels. The enhanced activity of ATP releasing 
channels  in  some  mutants  (G138R  and  G143S)  can  be  explained  by  an  obvious 
degradation defect seen in pulse-chase analyses (Fig. 4.26). The increased function of 
these  channels  observed  in  the  I31M mutant  showing  a  normal  half-time  cannot  be 
explained by an increased amount of Cx43 hemichannels in the membrane. Thus, it is 
possible that the I31M mutation localized in the first transmembrane domain, which is an 
important determinant of conductance (Hu et al., 2006), changes the properties of Cx43 
and activity of ATP releasing channels. Data regarding the H194P mutant are similar to 
those reported for the Cx43 cysteine-less mutant (Bao et al., 2004), which also revealed a 
lack of gap junction plaques but still indicated functional hemichannels.
It is possible that mutations in the cytoplasmic loop of Cx43 like the G143S or G138R 
may favor the binding of the C-terminus to the loop disturbing the degradation of these 
proteins. The importance of the C-terminus for Cx43 degradation could be shown in the 
characterization  of  its  truncated  mutant,  the  Cx43K258stop  (Maass  et  al.,  2004).  A 
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degradation  impairment  leads  to an  enrichment  of  the  protein  in  distinct  cell 
compartments. One of these compartments is the plasma membrane. Here, the increasing 
amount  of  connexin  proteins  results  in  an  increased  number  of  hemichannels.  The 
properties of the hemichannels themselves may not be altered by these mutations. The 
Cx43 localization in G138R mutated hearts supports this assumption. Here, the Cx43 
positive staining could be detected in intercalated discs between two cardiomyocytes but 
also shows a tendency to accumulate in lateral membranes (see Fig. 4.6G-H). 
5.5 Different ODDD mouse models and Cx43G138R expressing mice
Until now, three mouse models have been generated, showing ODDD like phenotypes, 
the  Cx43G61S (Flenniken et  al.,  2005),  Cx43G138R (Dobrowolski  et  al.,  2008)  and 
Cx43I130T (Kalcheva et al., 2007) expressing mice.
Besides the development of diverse ODDD characteristics, striking cardiac phenotypes 
are present in all models, although only for one of the three mutations, the I130T, cardiac 
arrhythmias  were  described  in  the  corresponding  patients  (Paznekas  et  al..,  2003). 
Unfortunately, it  is uncertain whether the cardiac phenotype in Cx43I130T expressing 
mice  is  specific  for  this  mutation  or  shares  a  similar  mechanism  to  the  other  two 
mutations also leading to arrhythmias. 
In  human,  ODDD associated  cardiac  symptoms  are  relatively  rare.  This  discrepancy 
between human and mice could be explained by intra- and interfamiliar variability as 
already seen in other symptoms of ODDD like syndactylies (Debeer et al., 2005). The 
individual genetic background in each patient could be responsible for the variability. 
This aspect has already been proposed for the high variability in symptoms of Cloustron 
syndrome caused by Cx30 mutations (van Steensel  et  al.,  2004) or caractogenesis  in 
Cx50 null  mutated mice (Gerido et al.,  2003). Thus, variability between the different 
ODDD mouse models regarding the cardiac phenotype does not occur, since they have a 
similar genetic background. 
It is hard to predict a potential genetic modifier altering the severity or appearance of 
cardiac  arrhythmia  in  ODDD  as  already  described  for  calpain  3  in  caractogenesis 
90
                                                                                                                             Discussion  
(Baruch et al., 2001). However, recently  KCNJ2 gene coding for Kir2.1, a K+ subunit 
important for the maintenance of resting potential in cardiomyocytes, has been described 
to be closely regulated with Cx43 by the microRNA miR-1 (Yang et al., 2007). Until 
now, however, a defined connection between ODDD associated cardiac symptoms and 
the KCNJ2 gene expression has not been reported. 
A possible explanation for the interfamiliar variability could also be due to functional 
differences between the single mutations. Recently, different potency of the G21R and 
G138R mutations  has been described:  the G21R mutated Cx43 is  twice as  potent  in 
inhibiting the wild-type Cx43 function as the G138R mutant protein (Gong et al., 2007). 
There are obvious differences between the Cx43G138R expressing mice and the other 
two ODDD mouse models, the most striking are cardiac phenotypes. The three ODDD 
mutants as well as the cardiac specific Cx43 deficient mice are precisely compared  in 
Table 5.2 on the following page. It can be affirmed that G138R mutated mice show the 
strongest cardiac phenotype by developing severe spontaneous VTs to 100%, whereas 
such events could be detected in only 25% of the investigated I130T or in none G60S 
mutants. Furthermore, the Cx43G138R expressing mice showed Cx43 positive staining 
in the intercalated discs, while the other ODDD mutants did not, nevertheless, the G138R 
mutated cardiomyocytes exhibit a strong reduction of coupling. 
The activity of hemichannels in mutated hearts was only investigated and described in 
the Cx43G138R mice. In primary cardiomyocytes these channels could be stimulated by 
zero calcium conditions and hypoxia, hypoxic periods resulted in vivo in clear increase of 
arrhythmic events. Moreover, the observed embryonic lethality in these mutants was due 
to the cardiac expression of the mutation and emerged during ED 13-16.5, a period in 
which cardiomyocytes fully adopt their metabolism to oxygen. These facts underline the 
importance of the action of these ATP releasing channels in the cardiac physiology and 
remain to be checked in the other ODDD mouse models.
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Table 5.2: Comparison of cardiac function in ODDD mouse models vs conditional Cx43 mutant (Cx43fl/fl:alphaMyHC-Cre). All ODDD mutated mice 
developed cardiac anomalies in a dominant manner. Notice the lack of Cx43 expression in all except the Cx43G138R mutant, as well as strong 
penetrance of sustained spontaneous ventricular tachycardias (VTs) in this ODDD mouse model.
 Cx43fl/fl:alphaMyHC-Cre Eckardt et al., 2006 
Cx43 +/floxG138R:alphaMyHC-Cre 
Dobrowolski et al., 2008 
Cx43 +/G60S 
Flenniken, Osborne et al., 2005 
Cx43 +/I130T 
Kalcheva et al., 2007 
Genetic 
conspicuousness 
Heterozygous: 
rezessive 
Homozygous: 
phenotype 
Heterozygous: 
dominant 
Homozygous: 
not viable 
Heterozygous: 
dominant 
Homozygous: 
lethal 
Heterozygous: 
dominant 
Homozygous: 
lethal 
lifespan - 16 days after birth (PD) 4 – 6.5 months ED 13 – 16.5 normal - normal - 
Embrynonic 
lethality 
 
- 
32 % 
(25% expected,17% born) 
44 % 
(25% expected, 14% born) 100 % - 100 % 
36% 
(50% expected, 32% born) 100 % 
QRS (ms) n.s. 
676 % 
(85.9±14.1 vs +/fl: 
12.7±1.6) 
170 % 
(23.8±4.4 vs +/+: 14.0±0.8) - 
2 out of 9 mutants: 
prolonged - 
n.s. (p=0.1) 
(12.3±1.0 vs +/+10.5±0.3;) - 
Ampl. R (mV) n.s. 
5.8 % 
(0.18±0.06 vs +/fl: 
3.12±0.97) 
22 % 
(0.12±0.02 vs +/+: 0.55± 0.07) - n.s. - 
30 % 
(1.4 vs 4.6) - 
PQ (ms) n.s. n.s. 124 % (53.0±2.0 vs 42.8±6.3) - n.s. - n.s. 
 
- 
Cx43 trafficking reduced by  50%, normal 
No protein in 
cardiomyocytes 
plasma membrane 
(widely normal) - 
Widely not localized in 
plasma membrane - 
Widely not localized in 
plasma membrane - 
Reduction of 
coupling 
50% in 
cardiomyocytes 
100 % in cardiomyocytes 
(Cx43 ablation, 
immunfluorescence data) 
94 % in cardiomyocytes 
(microinjection data) - Very weakly coupled - 
50% 
(7.9±2.4 vs 15.7±1.4) - 
Hemichannel 
activity in 
cardiomyocytes 
50% in 
cardiomyocytes 
0 % in cardiomyocytes 
loss-of-function mutation 
200 % 
gain-of-function mutation 200 % Not known - Not known - 
Heart morphology n.s. 
hypertrophy in 
subpulmonal region of the 
outflow tract 
n.s.  - Patent foramen ovale - n.s. - 
Echocardiography n.s. n.s. n.s.  - 
Preejection + ejection 
time elevated, diastolic 
chamber dimension + 
thickness reduced 
- n.s. - 
Arrhythmogeneity n.s. 
0 % 
spontaneous VTs 
 
Small amplitudes + 
broadening of the 
complexes => diffuse 
ventricular activation => 
strong reduction of QRS 
amplitudes 
100 % 
spontaneous ventricular 
tachycardias (VTs) 
- 
0 % 
spontaneous VTs 
 
56 % bradycardia 
44 % sinus arrest 
11 % sinus arrest 
11 % sinus 
dissociation  
- 
25 % 
spontaneous VTs 
 
75 % 
inducible VTs 
- 
Cause of death  - 
Irregular ventricular 
activation suspected 
Ventricular tachycardia (VT) 
favored by hypoxic stimulation Not known Bradycardia suspected Not known Not known Not known 
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5.6 The morphological ODDD phenotype can be explained by a reduced 
Bmp2 and Shh expression 
After ubiquitous activation of the mutated Cx43G138R gene in the transgenic mice, all 
morphological  ODDD  phenotypic  manifestations  described  in  patients  including 
syndactyly,  craniofacial  and  bone  abnormalities  were  found.  These  abnormalities 
demonstrate  the importance of Cx43 during embryonic development  and confirm the 
identity of this ODDD mouse model. 
The reduced expressions of the two key morphogens, not only for the limb and bone 
formation, Shh and Bmp2 (see Fig. 4.17 and 4.19), can explain the phenotypes in ODDD 
mutated mice and patients. 
The  bone  phenotype  observed  in  heterozygously  mutated  mice  (Fig.  4.3)  could  be 
explained by the obviously reduced osteoblast number, which, however, did not reach 
significance because of the strongly variable phenotype of the male mutants. The reduced 
expression of Bmp2 could be the reason for the reduced osteoblast's portion in mutant 
bone. Bmp2 is described to be crucial for the differentiation of mesenchymal precursor 
cells to osteoblasts (Thies et al., 1992). 
The craniofacial malformations seen in ODDD mutants (Fig. 4.2H) are similar to those 
described for mouse embryos with a reduced Shh expression. These wild-type embryos 
were cultured in a cyclopamine conditioned solution, a Shh signaling antagonist (Nagase 
et al., 2005) and present an animal model for holoprosencephaly (HPE). This cephalic 
disorder  is  characterized  by  an  impaired  development  of  the  embryonic  forebrain, 
prosencephalon, causing facial and sometimes brain defects. HPE is known to be mainly 
caused by Shh mutations or to have environmental causes in man (Roessler et al., 1996). 
An extremely high intra- and interfamiliar variability is reported in HPE patients which 
ranges from cyclopia and perinatal lethality to hypotelorism (abnormal closeness of the 
eyes),  microcephaly  and  dental  malformations  (Cohen  et  al.,  1989a,b  and  1992). 
Interestingly,  malformations  described for  mild forms  of  HPE equal  those in  ODDD 
patients. The cause for this analogy could be a reduction of the Shh induced signaling 
and its influence of the downstream affected pathways like that of Bmp2. 
Also  the  observed  enamel  hypoplasia  in  Cx43+/G138R  mice  (Fig.  4.2G)  can  be 
explained with a reduction of the Bmp2 expression in  mutants.  Bmp2,  besides  other 
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members of this gene family, was found in the enamel knot, the putative signaling center 
regulating tooth shape, and is expressed there by the dentin-forming odontoblasts and the 
enamel  forming  ameloblasts  (Aberg  et  al.,  1997).  However,  a  reduction  of  Bmp2 
expression does not result in a dental patterning defect but reduces the enamel thickness 
(Zhao et al., 2000). 
The disturbed interdigital apoptosis in the G138R mutated mice leading to the observed 
syndactylies  is  most  likely  due  to  a  decreased  Bmp2  level  and  not  an  excessive 
expression of its antagonist Noggin in the developing limb (Fig. 4.17). Bmp2 is known to 
induce cell death between the digits and separating them from each other  (Ganan et al., 
1996; Yokouchi et  al.,  1999; Zou and Niswander, 1996). An immoderate blockade of 
apoptosis  could  be  excluded  because  no  differences  in  Noggin  expression  in  the 
developing  hands  or  feet  were  seen  between  the  two  genotypes.  In  order  to  further 
quantify the amount of Bmp2 in the limb bud, cultures were assessed and western blot 
analyses were provided. The reduction of Bmp2 levels already seen in fused neural tube 
or head in whole mount embryos (Fig. 4.17) could also be confirmed in the limb bud 
(ED11.5 and ED13.5) (Fig. 4.19).
It has been hypothesized that the amount of certain morphogen is crucial for a proper 
development  of  the  distinct  tissue,  as  described  by Bandyopadhyay et  al.  (2007)  for 
Bmp2, 4 and 7. The lowered quantity of Shh, Bmp2 or their downstream signaling could 
lead to the observed phenotypic variability in the heterozygously mutated Cx43G138R 
mice, ODDD and HPE patients. 
Thus, ODDD patients may show a reduction in Bmp2 and Shh expression which would 
lead to the known morphological anomalies. Because Bmps are expressed in adult bone 
(Daluiski et al., 2001) a biopsy of bone matter from an affect person would be sufficient 
to quantify the transcripts of the mentioned genes. 
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5.7 Cx43 mediated coupling modulate morphogen expression in limb bud 
and bone
In order to investigate the molecular reasons for the morphological malformations in the 
ODDD mice hemizygous mutants were used. These Cx43LacZ/G138R mice showed a 
high penetrance of the ODDD phenotype. The immunohistochemical analyses of whole 
mount  embryos  (ED10.5  –  ED13.5)  and  limb  bud  culture  experiments  revealed  an 
alteration of two major morphogens in the mutant mice, i.e. proteins with an ability to 
induce proliferation and regulate tissue patterning. These two morphogens were sonic 
hedgehog  (Shh)  and  bone  morphogenic  protein  2  (Bmp2),  whereas  all  other  tested 
proteins  (Bmp4,  FGF8  or  Noggin)  showed  no  changes  between  the  genotypes. 
Furthermore, the  combination of control animals (wild-type and Cx43 deficient mice) 
allows to conclude that the decreased expression of Shh and Bmp2 is due to a disruption 
of  Cx43  mediated  gap  junctional  coupling. This  assumption  is  supported  by  the 
appearance of morphologic ODDD specific symptoms in heterozygously mutated mice 
or human patients carrying other Cx43 mutations. The occurrence of the syndactylies or 
craniofacial alterations in patients with GJA1 gene mutations not altering the activity of 
ATP releasing channels (Lai et al.,  2006), exclude their action as the reason for these 
symptoms. 
Function,  expression  pattern  and  signaling  pathways  of  both  morphogens  are  well 
described.  It  is also known that Shh signaling acts upstream of Bmp2 (Laufer et  al., 
1994)  (see  Fig.  1.8).  This  fact  suggests  that  the reduced expression  of  Shh seen in 
ODDD mice is the cause for the reduced Bmp2 expression in these mutants. 
However, the precise molecular mechanism how Cx43 influences the expression of these 
morphogens is not known. The link between Cx43 and Shh or Bmp2 transcription could 
be provided by studies using Cx43-antisense nucleotides in chick limbs. Here, the knock-
down of Cx43 expression led to a reduction of both morphogens mRNA levels. Recently, 
Shh signaling has been described to be associated with an increase of intracellular Ca2+ 
concentration which mediates proliferation signals in mouse ES cells (Heo et al., 2007). 
Since it is well known that Cx43 containing gap junction channels are able to transfer 
Ca2+ or inositol-1,4,5-trisphosphate (IP3) (Saez et al., 1989), calcium imaging studies of 
wild-type and mutated primary limb bud cells were performed. During these analyses it 
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could  be  observed  that  neither  Cx43LacZ/G138R  nor  Cx43  deficient  cells  could 
propagate spontaneous Ca2+ oscillations to neighboring cells. This behavior was contrary 
to  wild-type  cells  (Fig.  4.20F-J).  Thus,  it  is  possible  that  Ca2+ acts  as  a  morphogen 
modulator and the disturbed Ca2+ propagation results in a reduced Shh signaling which in 
turn leads to a diminished Bmp2 expression. This hypothesis will be further clarified in 
ongoing analyses.
However, it cannot be excluded that small molecular messengers other than proteins are 
involved in this processes. Serotonin is such a molecule which signaling is crucial for 
patterning of the left-right axis (Fukumoto et al., 2005). The transfer of serotonin and 
possibly  other  small  morphogens  through  long-range  gap  junctional  channels  is 
apparently driven by an electrophoretical mechanism (Esser et al., 2006). This signaling 
process  influence  the  lateral  expression  of  the  marker  proteins  Nodal  and  sonic 
hedgehog, i.e. acts upstream of the corresponding genes (Levin and Mercola, 1999). 
5.8 Impact of the Cx43G138R mutation on the brain 
The Cx43G138R mutated gene is driven by the endogenous Cx43 promoter which allows 
its expression in astrocytes of the adult brain (Fig. 4.13). The G138R mutation leads to a 
gap junction channel blockade and increased activity of ATP releasing channels. Both 
effects influence processes in the brain. Specific deletion of Cx43 in astrocytes results in 
deceleration  of  spreading  depression  and  locomotory  activity,  whereas  the  resulting 
reduction of gap junctional coupling appears to be compensated by Cx30 up-regulation 
(Theis et al., 2003). 
The activity of Cx43 hemichannels was recently described to play a central role in the 
hypoxic preconditioning in the brain (Lin et al., 2008). Cx43 supported or mediated ATP 
release  and  an  accumulation  of  its  metabolic  product  and  a  neuroprotective  agent 
adenosine elevate cellular resistance to subsequent hypoxic events (Lin et al., 2008). 
During this PhD work two ODDD mutants were analyzed which could be very helpful to 
further reveal the influence of connexin mediated intercellular coupling and increased 
activity  of  ATP  releasing  channels  on  processes  in  the  brain.  The 
Cx43flox/floxG138R:Nestin-Cre mice are the only living homozygous ODDD mutants. 
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Since the heterozygously G138R mutated mice show in comparison to wild-type ones a 
doubled activity of the ATP releasing channels, it can be expected that the homozygous 
mutants  show  a  fourfold  increased  activity  of  these  channels.  Consequently,  these 
homozygous  brain  specific  mutants  are  suitable  to  further  analyze  the  impact  of 
hemichannels  in  vivo.  An  increased  adenosine  concentration  and  an  associated 
neuroprotection can be expected.  However,  a gain-of-function mutation regarding the 
ATP releasing channels in the brain has not been described till now, the consequences of 
an  increased  efflux  of  signaling  molecules  and  ions  remain  unpredictable.  In  this 
homozygous mutant the Cx43 mediated coupling is similar to Cx43 deficient mice. As 
shown in Figure 4.21 the Cx43G138R mutation dominantly inhibits Cx43 coupling in 
stably transfected HeLa cells, also the generation of the functional Cx43G138R/Cx43WT 
heterotypic channels is not possible in astrocytes of these mice. Furthermore, the gap 
junctional coupling seems to be compensated by Cx30 up-regulation in the homozygous, 
brain specific  ODDD mutants  (see Fig.  4.15 bottom right).  Hence,  conditional  Cx43 
knock-out mice (for example Cx43flox/floxLacZ:Nestin-Cre) are the adequate controls 
for the subsequent analyses (see chapter 5.9 Future perspectives). 
The  second  interesting  mutant  are  the  hemizygous  Cx43LacZ/G138R  mice.  The 
connexin expression in these mice is strongly decreased (see Fig. 4.15). Cx43 expression 
is reduced to 15%, whereas the amount of Cx30 is not significantly altered. The missing 
compensation by Cx30 could provide for widely pronounced phenotype. 
97
                                                                                                                             Discussion  
5.9 Future perspectives
The Cx43G138R mouse model of ODDD will be further used to analyze the effects of 
increased activity of ATP-releasing channels and reduction of gap junctional function on 
bone  formation,  syndactyly  and  astrocytic  functions.  In  addition,  the  Cx43G138R 
mutated  mice  may  serve  as  a  useful  platform  to  test  therapies  against  Cx43 
dephosphorylation, gap junction channel closure and increased activity of ATP releasing 
channels. 
5.9.1 Bone morphogenesis in Cx43G138R mice
Further analyses of bone morphogenesis will be provided in cooperation with the group 
of  Prof.  Roberto  Civitelli  (St.  Louis,  USA).  In  order  to  define  the  impact  of  the 
Cx43G138R on the development  of  bone several  histological  stainings  will  be done. 
Thus,  tartrate-resistant  acid  phosphatase  (TRAP)  analyses  for  osteoclasts,  trichrome 
staining for osteoblasts  as well  as calcein injections for whole mineralized tissue are 
planed. Furthermore, the dominant-negative effect of the mutant Cx43 protein will be 
investigated in reference to early osteoblast commitment of stromal cell precursors. A 
possible  impairment  of  the differentiation of these cells  would explain the obviously 
decreased  number  of  osteoblasts  in  ODDD  mutated  bones.  The  use  of  different 
Cx43G138R  mutants  like  hemizygous  Cx43G138R/LacZ  mice  or  the  homozygous 
Cx43flox/floxG138R:Dermo1-Cre  and  Runx2-Cre  mediated  ubiquitous  or  specific 
activation in osteoblasts will help to resolve this problem. 
5.9.2 The impact of the Cx43G138R mutation in brain 
In cooperation with groups of Prof. Maiken Nedergaard (Rochester, NY, USA) and Dr. 
Martin Theis (Bonn, Germany) the impact  of the increased activity of ATP releasing 
channels and reduction of gap junctional coupling in the brain will be investigated. 
The use of  two photon microscopy allows real-time imaging of  cellular  processes in 
living brains such as neuronal  degeneration or neuroprotection.  Specific excitation of 
eGFP, which is expressed in Cx43G138R positive cells, allows to distinguish astrocytes 
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releasing  ATP  in  vivo and  precisely examine  their  cellular  behavior  as  well  as  their 
influence on other direct cell neighbors. As already mentioned above, Cx43 mediated 
release  of  ATP and an  accumulation  of  adenosine  during  hypoxic  preconditioning  is 
described to protect cells from subsequent hypoxic stress (Lin et al., 2007). The gain-of-
function  of  these  ATP releasing  channels  will  be  further  analyzed  using  the  G138R 
expressing mice in the hypoxia model. 
Furthermore, hemizygous mutants as well as early neuron specific homozygous ODDD 
mutants will be investigated during kainate induced epilepsy.  The determination of the 
status epilepticus in Cx43G138R mice should elucidate the function of hemichannels in 
the brain. 
5.9.3 Modulation of morphogen expression by gap junctional coupling
To further understand the molecular mechanisms behind the modulation of morphogen 
expression by gap junctional coupling diverse in vitro and in vivo experiments are planed. 
The possible modulation of Shh and Bmp2 expression by Ca2+ or IP3 signaling will be 
investigated in limb bud cultures. Here, an increase of the frequency of intercellular Ca2+ 
oscillations  will  be  provided  by  long-term  application  of  carbachol  (up  to  3  days). 
Because carbachol's maximal action last only for an average of 8 hours, the drug has to 
be reapplied after  this  time.  The expression of  the morphogens will  be subsequently 
tested  in  quantitative  real-time PCR analyses  in  cooperation  with  the  group of  Prof. 
Michael Hoch (Bonn, Germany). 
The  possible  involvement  of  small  morphogenic  molecules,  like  serotonin,  on  the 
expression of Shh and Bmp2 can also be examined in the primary cell cultures. Thus, 
serotonin can be applied over a long time and is easy to handle because of its relatively 
long half-life time of up to 48 h. In addition, serotonin has also been described to be 
involved in craniofacial development (Lauder et al., 1988) by regulation of cranial neural 
crest migration (Moiseiwitsch et al., 1995). However, a direct influence of serotonin on 
Shh or Bmp2 expression has not been described. The transcripts of these two genes will 
also be quantified in real-time PCR analyses.
Subsequent  in vivo and in vitro imaging of Ca2+ or IP3 propagation in the developing 
mouse limb buds will be performed in cooperation with Dr. Hartmann Hartz (Munich, 
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Germany).  In  vivo studies  can  be  performed  using  two  photon  microscopy.  These 
analyses will further illuminate the possible interaction of Ca2+ and morphogen signaling.
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6. Summary
The Cx43G13R expressing mice present a new conditional mouse model for ODDD, 
carrying  the  human  G138R point  mutation.  The  main  findings  of  this  study are  the 
occurrence  of  all  common  phenotypes  of  the  human-inherited  disease  ODDD,  like 
syndactylies, craniofacial anomalies, enamel hypoplasia, and the heart related mortality 
of Cx43G138R heterozygously mutated mice. The mortality of the mice is likely due to 
the strongly decreased gap junctional function, supporting the proarrhythmic action of 
the  G138R-mutated  Cx43  protein.  This  appears  to  be  associated  with  a  strongly 
diminished phosphorylation (P2 band) of this protein. The expression of the mutant Cx43 
in HeLa and ES cell as well as the use of primary cardiomyocytes derived from mutant 
embryonic hearts revealed besides a strong decrease of Cx43 mediated gap junctional 
coupling and increased activity of ATP releasing channels. The physiological relevance 
of both effects could be ascertained in vivo. Impulse propagation and activation pattern 
could be determined in Langendorff recordings and surface ECGs showing a striking 
broadening  of  the  QRS  complex  and  chaotic  appearance  of  field  potentials  in 
heterozygously mutated hearts. These data are similar to those obtained with conditional 
Cx43 deficient mice, suggesting the loss Cx43 mediated coupling to be responsible for 
the observed alterations. However, also the increased activity of ATP releasing channels 
in mutant hearts was physiologically relevant. In order to investigate the impact of the 
ATP releasing channels in the heart, primary cultures of cardiomyocytes were established 
and further characterized. Noticeably, beating frequency of mutated cardiomyocytes was 
faster than that recorded in wild-type cells. Using the gap junction blocker flufenaminic 
acid  (FFA)  at  a  concentration  inhibiting  ATP-releasing  hemichannels  or  the  mimetic 
peptide  Gap26 as  a  specific  blocker  of  these channels  reduced the  increased  beating 
frequency of mutated cardiomyocytes in culture to the same level as observed in wild-
type  cells.  This  suggests  that  the  spontaneous  ventricular  arrhythmias  observed  in 
Langendorff and in vivo recordings of mutated adult hearts are mainly due to the strongly 
decreased gap junctional coupling and could be aggravated by the increased release of 
cellular ATP or other small molecules. 
Furthermore, the morphological anomalies of the ODDD mutated mice could be referred 
to a obviously reduced expression of two key morphogens: sonic hedgehog (Shh) and 
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bone  morphogenic  protein  2  (Bmp2).  Diminished  levels  of  these  proteins  lead  to  a 
deficient induction of interdigital apoptosis by Bmp2 causing syndactylies. In addition, 
impaired development of the embryonic forebrain by Shh, may cause facial defects.
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8. List of abbreviations
A adenin
A Ampere
AER apical ectodermal ridge
alphaMyHC alpha myosin heavy chain
ATP adenosine triphosphate
BSA bovine serum albumin
bp base pairs
Bmp bone morphogenic protein
bpm beats per minute
C cytosin
Ca calcium
cAMP cyclic 3’,5’-adenosine 
monophosphate
cDNA copy DNA, reverse transcribed 
mRNA
CFP cyan fluorescent protein
ChAT choline acetyltransferase
Cl chloride
C-terminus carboxy-terminus
Cx connexin
Da Dalton
DNA desoxy ribonucleic acid
dNTP 2’-desoxy-nucleoside-5’-
triphosphate
ECG electrocardiogram
E. coli Escherichia coli
EB embryoid body
ED embryonic day
EF left ventricular ejection fraction 
e.g. for example 
(Latin: exempli gratia)
eGFP enhanced green fluorescent 
protein
ES cell embryonic stem cell
EtBr ethidium bromide
FFA Flufenaminic acid
Fig figure
FITC fluorescein isothiocyanate
g gram
G guanin
GFAP glial fibrillary acidic protein
gj unitary conductance
Gj transjunctional conductance
GJC gap junction channel
h hour
HF heart frequency
HPE holoprosencephaly
Hz Hertz
i.e. that is (Latin: id est )
IgG immunoglobulin G
Ij transjunctional current
IP3 inositol 1,4,5-trisphosphate
IRES internal ribosomal entry site
isoOMPA tetraisopropylpyrophosphoamide
kb kilo base pairs
KO knock-out
l liter
LVM left ventricular muscle mass
LVEDV left ventricular enddiastolic 
volume
m meter
M molar
Mg magnesium
min minute
Na sodium
NAD nicotinamide adenine 
dinucleotide
neurobiotin N-(2-aminoethyl)biotinamide
neo neomycin resistance gene
NGS normal goat serum
NLS nuclear localization signal
ODDD oculodento digital dysplasia
PB phosphate buffer
PBS phosphate buffered saline
PCR polymerase chain reaction
PFA paraform aldehyde
PGK phosphoglycerate kinase 
promoter
PI propidium iodide
PIP2 phosphatidylinositol bisphosphate
pH negative decadic logarithm of
hydrogen ion concentration
PLCß3 phosphatidylinositol bisphosphate 
hydrolyzing receptors
PKC protein kinase C
RNA ribonucleic acid
RT-PCR reverse transcriptase-polymerase 
chain reaction
s second
S Siemens
Shh sonic hedgehog
T thymidin
Tab. Table
UTR untranslated region
V volt
VES ventricular extra systole
Vj transjunctional voltage
vol volume
VT ventricular tachycardia
ZO-1 zonula occludens protein 1
ZPA zone of polarizing activity
Ω Ohm
°C degree Celsius
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9. Supplement 
9.1 Cloning of the conventional Cx40A96S construct
In order to investigate the molecular mechanisms and to develop strategies how to avoid 
idiopathic atrial fibrillations in patients carrying the Cx40 A96S point mutation (Gollob 
et  al.,  2006), the decision has been made to generate a mouse model expressing this 
mutated  protein.  The  following figures  present  the  generation  of  the  non-conditional 
Cx40A96S construct.
The  resulting  Cx40A96S  conventional  mouse  vector  has  a  total  size  of  13253  bp 
including a 5' homology region of 5031 bp and a 3' homology region of 1560 bp. 
As already described for the conditional  Cx43G138R mouse vector  the use of eGFP 
allows to in vivo label the cells expressing the mutated form of Cx40 without affect the 
expression of the Cx40 proteins. The PGK-Neomycin cassettes are flanked by frt sites 
and have to be excised using the deleter/Flp mice to avoid the strong PGK promoter 
activity. 
The  Cx40A96S vector  has  been  used  in  cooperation  with  the  diploma student  Indra 
Luebkemeier  for  homologous  recombination  in  mouse  ES  cells  and  will  be  further 
analyzed in vivo. 
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Figure 9.1: The cloning strategy for the conventional Cx40A96S mouse construct consists of at 
last five cloning steps and result in the 13.3 kb mouse vector.
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Figure 9.2: Control digestions of the Cx40A96S mouse vector. (A) All used restriction enzymes 
showed a expected digestion pattern (see table) as could be detected on the shown agarose gel. 
(B) The sequencing of the final vector was performed by 4baseLab (Reutlingen, Germany) and 
approved the proper sequence of regions marked by arrows. 
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   5' HR             5' HR    IRES             3' HR
extension          Cx40A96S        eGFP      PGK-Neo
frt         frt
pBSK
Sequencing directions
Enzyme
Expected
fragment 
sizes
A
B
13253 10819 9925 13253 5747 6304 5277 4487 9535 5718 5224 4997 8167 5767 10411 12350
2434 2980 3957 3370 3614 3295 3140 4656 3951 2341 5086 4797 2842 903
348 3549 2228 2496 3228 578 2879 3280 2296 2689
1351 970 1856 798 1882
480 387 905
416 635
197
NotI NheI HindIII ClaI AvaI NcoI BamHI XbaI SacI HincII KpnI PstI StuI EcoRV ScaI NsiI
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9.2 Vector maps
Figure 9.3: The vectors  pIRES (clontech)  and pMJ-Green (Maxeiner  et  al.,  2005)  and PCR 
amplicons  containing  mutated  Cx43  coding  regions  were  used  to  clone  the  eukaryotic 
IRES:eGFP:Zeo:ODDD vectors. These vectors were used to express the mutated Cx43 G138R, 
I31M, I143S and H194P proteins in HeLa cells. In these cells CMV promoter drives the Cx43 
ODDD mutations followed by the IRES cassette (internal ribosomal entry site) and eGFP. This 
combination of gene cassettes facilitated the expression of the eGFP reporter in cytoplasm of 
cells expressing the mutant proteins. 
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